Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E28.66 EPS (ttm)0.97 Insider Own0.50% Shs Outstand2.53B Perf Week-0.96%
Market Cap70.61B Forward P/E15.17 EPS next Y1.84 Insider Trans0.00% Shs Float2.50B Perf Month0.18%
Income2.47B PEG- EPS next Q0.59 Inst Own13.90% Short Float0.98% Perf Quarter-10.75%
Sales23.82B P/S2.96 EPS this Y128.90% Inst Trans-0.07% Short Ratio3.21 Perf Half Y-7.48%
Book/sh5.17 P/B5.40 EPS next Y-10.90% ROA3.90% Target Price34.12 Perf Year-5.11%
Cash/sh1.58 P/C17.66 EPS next 5Y-1.00% ROE16.50% 52W Range25.55 - 34.58 Perf YTD2.16%
Dividend0.90 P/FCF- EPS past 5Y-16.70% ROI11.50% 52W High-19.28% Beta0.75
Dividend %3.22% Quick Ratio0.70 Sales past 5Y-5.80% Gross Margin82.70% 52W Low9.24% ATR0.44
Employees61500 Current Ratio0.80 Sales Q/Q-4.10% Oper. Margin14.50% RSI (14)50.11 Volatility1.23% 1.19%
OptionableYes Debt/Eq1.35 EPS Q/Q31.60% Profit Margin10.40% Rel Volume0.48 Prev Close28.50
ShortableYes LT Debt/Eq1.13 EarningsFeb 02 BMO Payout97.50% Avg Volume7.61M Price27.91
Recom2.20 SMA200.27% SMA501.93% SMA200-6.33% Volume3,688,676 Change-2.07%
Dec-09-16Upgrade Leerink Partners Mkt Perform → Outperform
Nov-25-16Upgrade Liberum Hold → Buy
Sep-23-16Initiated Piper Jaffray Overweight
Sep-12-16Upgrade Jefferies Hold → Buy
Aug-29-16Upgrade Argus Hold → Buy
Jul-12-16Initiated Argus Hold
Apr-12-16Downgrade Goldman Neutral → Sell
Mar-15-16Downgrade Jefferies Buy → Hold
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-08-16Downgrade HSBC Securities Buy → Hold
Jan-19-16Upgrade Barclays Underweight → Equal Weight
Dec-01-15Upgrade Morgan Stanley Underweight → Overweight
Nov-02-15Downgrade Nordea Buy → Hold
Oct-20-15Downgrade Credit Suisse Neutral → Underperform
Sep-18-15Upgrade Bryan Garnier Neutral → Buy
Jul-31-15Upgrade Swedbank Neutral → Buy
Jul-02-15Upgrade Berenberg Hold → Buy
Apr-15-15Initiated Societe Generale Buy
Sep-22-10Reiterated Barclays Capital Equal Weight $225 → $230
Jul-29-10Downgrade Standpoint Research Buy → Hold $60
Jan-19-17 12:56PM  [$$] GSK appoints AstraZeneca executive as global head of pharma at Financial Times
07:00AM  This Could Be The Biggest Winner Of 2017s Biotech Boom
05:13AM  GSK grabs Astra executive to replace pharma head
Jan-18-17 08:30AM  AstraZeneca Offers Update on Immuno-Oncology Program
Jan-17-17 04:32PM  FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink
08:54AM  [$$] AstraZeneca expands trials for key cancer drug at Financial Times
Jan-16-17 12:04PM  Dodge & Cox's Stock Fund 4th Quarter Commentary
Jan-12-17 04:04PM  Bristol-Myers Threatens Merck's 'Head Start' In Lung Cancer: Analyst
10:37AM  Mylans Specialty Segment: The Effect of Falling EpiPen Sales
04:47AM  European Pharma Shares Hammered After Trump Press Conference Attack
Jan-11-17 04:33PM  Bristol-Myers and AstraZeneca Take Beatings
01:03PM  2 Stocks For a Trump-ed Up Pharma Market at Barrons.com
12:28PM  Merck Lung-Cancer Drug May Get OK For Large Patient Population
12:09PM  European stocks trim gains after Trump comments send drug stocks lower at MarketWatch
Jan-10-17 09:30AM  Can AstraZeneca (AZN) Be a Solid Choice for Value Investors?
Jan-09-17 06:51PM  [$$] Chance for an agile new drug approval system at Financial Times
05:30PM  Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline at Forbes
01:33PM  Bullish and Bearish Reversals in the Market
Jan-05-17 11:04AM  Shell, AstraZeneca Could Surprise in 2017, Credit Suisse Says
Jan-04-17 12:00PM  Here's Why General Motors Is One of Wednesday's Most Active Stocks
Jan-03-17 01:43PM  AstraZeneca PLC (ADR) (AZN) Planning Tagrisso Label Expansion To Shore Up Earnings at Insider Monkey
10:11AM  AstraZeneca CIO Makes IT Twice As Good At Half The Cost - Here Is How at Forbes
06:37AM  Credit Suisse, AstraZeneca among top BofA-ML's top European picks for first quarter
Jan-02-17 09:06AM  AstraZenecas Lynparza Is Still a Leading PARP Inhibitor in 2016
07:36AM  Label Expansion May Boost Revenues for AstraZenecas Tagrisso
03:00AM  Mega Deals: Why the Outlook Is Uncertain at Investopedia
Dec-30-16 04:36PM  Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?
03:30PM  AstraZeneca plc (ADR) (AZN) CEO Claims The Drug Approval Process Of NHS Is Counterproductive at Insider Monkey
01:35PM  AstraZenecas Tagrisso Had a Strong Commercial Launch in 2016
01:19PM  10 Famous Corporate Whistleblowers in Publicly-Traded Companies at Insider Monkey
12:45PM  Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?
12:05PM  AstraZenecas Focused Strategy to Boost Future Revenues
10:20AM  AstraZeneca Could See Modest Fall in 2016 Revenues
Dec-29-16 11:30AM  [$$] AstraZeneca chief says NHS drug approval process hurts patients at Financial Times
10:36AM  Mercks Zetia and Vytorin: More Generic Competition in 2017
Dec-27-16 03:53PM  3 Biggest Risks for AbbVie in 2017 at Motley Fool
Dec-23-16 09:45AM  Stocks Open Tightly Mixed; Pfizer Climbs, Fred's Surges Again
Dec-22-16 08:01AM  Pfizer Ibrance sNDA Accepted by FDA under Priority Review
Dec-21-16 04:39PM  Alexion Announces Phase Two Trial Failure, Falls Slightly After Hours
Dec-20-16 04:25PM  Tesaro Ovarian Cancer Drug Gets Priority Review After FDA OKs Clovis Med
11:19AM  [$$] Pharma Picks as Fundamentals Weaken at Barrons.com
10:30AM  Conatus Pharma Doubles On Novartis NASH Liver Drug Licensing Deal
09:45AM  Endo finds new CFO in-house at bizjournals.com
Dec-19-16 08:41PM  Surprise! Clovis Oncology Nabs Early OK at Motley Fool
04:26PM  Clovis Stock Rallies After AstraZeneca-Rivaling Ovarian Cancer Win
04:14PM  Bristol-Myers Will Gain In Lung Cancer Square-Off Vs. Merck: Jefferies
04:02PM  Ionis and AstraZeneca Advance First Generation 2.5 LICA Drug into Preclinical Development to Treat Cardiovascular Disease PR Newswire
02:06PM  Why Jefferies Upgraded Bristol-Myers, Cut Merck at Barrons.com
02:01PM  [$$] Ashtead retreats on warning over US demand at Financial Times
12:25PM  Innate Pharma Pops as It Names AstraZeneca's Oncology Head as Chairman
09:09AM  Jefferies' Huge Pharma Pair Trade: Bristol-Myers Upgraded To Buy, Merck Downgraded To Sell
08:45AM  Ionis (IONS) Receives Milestone Payment from AstraZeneca
Dec-16-16 07:00AM  Ionis Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer PR Newswire
Dec-15-16 08:05AM  What Do Analysts Recommend for Pfizer?
Dec-14-16 01:50PM  Eli Lilly In 2017: Boom Or Bust? at Barrons.com
10:25AM  Endo unit launches generic version of Merck blockbuster at bizjournals.com
Dec-13-16 07:00PM  Cramer Remix: This groups out of the penalty box and on ...
04:21PM  Missing Phrase May Give Clue To Alexion Shake-Up, Analyst Says
12:22PM  Short-Sellers Are Betting Big Against Clovis Oncology -- Here's Why They're Probably Right at Motley Fool
10:14AM  Technology Ready To Cure Healthcare at Forbes
Dec-12-16 04:06PM  Alexion Tanks After CEO, CFO Unexpectedly Resign Amid Sales Probe
11:06AM  Why Alexion Pharmaceuticals, Inc.'s Shareholders Lost $3 Billion Today at Motley Fool
09:19AM  Lilly/AstraZeneca Expand Alzheimer Disease Collaboration
Dec-10-16 04:32PM  Big Alzheimer Flop Creates Buying Opportunity for Eli Lilly
Dec-09-16 09:24PM  How AstraZeneca plc (ADR) (AZN) Stacks Up Against Its Peers at Insider Monkey
04:09PM  Broadcom, Finisar Price Targets Hiked; AstraZeneca A Top Pick
12:02PM  AstraZeneca's immunotherapy enters U.S. approval process Reuters
11:24AM  Listing the Reasons behind Pfizers Discounted Price-to-Earnings
10:15AM  AstraZeneca Cuts 700 Jobs, Citing Falling Revenues at Investopedia
10:09AM  AstraZeneca PLC (ADR) (AZN) Cuts Jobs, Signs New Collaboration With Eli Lilly And Co (LLY) at Insider Monkey
08:28AM  Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs
08:07AM  Analysts' Actions -- Autodesk, Aflac, AstraZeneca, Duluth and More
07:40AM  AstraZeneca upgraded by Leerink Partners
07:12AM  Eli Lilly to pay AstraZeneca $30 million as part of a collaboration on an Alzheimer's treatment at MarketWatch
07:08AM  Eli Lilly and AstraZeneca to co-develop Alzheimer's Disease treatment at MarketWatch
Dec-08-16 05:13PM  Business Highlights
04:11PM  AstraZeneca cutting 700 U.S jobs, 120 in Phila. region at bizjournals.com
01:20PM  AstraZeneca cuts about 700 jobs, including 120 in Delaware
08:30AM  AstraZeneca Announces Subgroup Analysis from FALCON Trial Comparing FASLODEX® (fulvestrant) to ARIMIDEX® (anastrozole) Business Wire
Dec-07-16 04:04PM  Hanesbrands, AstraZeneca Plop into Wednesdays 52-Week Low Club at 24/7 Wall St.
01:30PM  Can AstraZeneca Plc (AZN) Lung Cancer Pill Take Over Chemo Treatment? at Insider Monkey
12:58PM  Top Research Reports for Cisco, Merck & MasterCard
10:21AM  Why AstraZeneca plc Stock Slumped in November at Motley Fool
09:25AM  AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting
Dec-06-16 12:30PM  AstraZeneca PLC (ADR) (AZN) Relocating Jobs At U.K. Division at Insider Monkey
12:15PM  AstraZeneca Reports Positive Lung Cancer Drug Trial Results at TheStreet
07:00AM  TAGRISSO® (osimertinib) Demonstrates Superiority over Chemotherapy in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer Business Wire
04:15AM  AstraZeneca pill slashes lung cancer progression in study
Dec-05-16 04:04PM  FitBit, Teva Slide into Mondays 52-Week Low Club at 24/7 Wall St.
12:21PM  Is Diageo plc (ADR) (DEO) A Good Stock To Buy? at Insider Monkey
12:21PM  Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-to-Treat Chronic Lymphocytic Leukemia Business Wire
Dec-02-16 08:04AM  Keytruda Is Mercks Immuno-Oncology Business
06:40AM  Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda
Dec-01-16 10:04AM  How Much Could Gilead Sciencess Revenues Fall beyond 2016?
09:30AM  Is Celgene Corporation (CELG) Worthy of Your Portfolio? at Insider Monkey
07:42AM  AstraZeneca in broad drug deal with Bicycle worth up to $1 bln Reuters
Nov-30-16 11:02AM  3 Horrible Stocks for Retirees at Motley Fool
Nov-28-16 08:49AM  Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALIOF
Nov-24-16 01:54PM  Should You Light Up An Investment In Reynolds American, Inc. (RAI)? at Insider Monkey
07:13AM  GSK chases Astra with start of big anaemia drug trials Reuters
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal diseases worldwide. Its marketed products comprise Accolate, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp, Duaklir Genuair, Eklira Genuair/Tudorza/Bretaris, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Rhinocort, Symbicort pMDI, and Symbicort Turbuhaler for respiratory, inflammation, and autoimmunity diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL, Tenormin3, and Zestril4 for cardiovascular disease; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic disease. The company's marketed products also include Arimidex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex, as well as Casodex, Cosudex for oncology disease; Fluenz/FluMist, Fluenz Tetra/FluMist Quadrivalent1, Merrem/Meronem2, Synagis3, and Zinforo4 for infection disease; Diprivan, EMLA, Movantik/Moventig, Naropin, Seroquel IR, Seroquel XR, Vimovo1, Xylocaine, and Zomig for neuroscience disease; and Losec/Prilosec and Nexium for gastrointestinal disease. It serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 146 projects, of which 125 are in the clinical phase of development. It has collaboration agreements with Celgene Corporation; Immunocore Limited; Heptares Ltd.; Foundation Medicine, Inc., French National Institute of Health and Medical Research (Inserm); and FibroGen and Astellas, as well as a research agreement with Eli Lilly. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom.
EBAY eBay Inc. daily Stock Chart
EBAY [NASD]
eBay Inc.
IndexS&P 500 P/E19.27 EPS (ttm)1.59 Insider Own6.40% Shs Outstand1.12B Perf Week1.02%
Market Cap34.41B Forward P/E14.80 EPS next Y2.08 Insider Trans-0.47% Shs Float1.04B Perf Month3.75%
Income1.86B PEG2.60 EPS next Q0.54 Inst Own86.00% Short Float1.49% Perf Quarter-2.91%
Sales8.91B P/S3.86 EPS this Y330.80% Inst Trans-0.03% Short Ratio1.42 Perf Half Y13.82%
Book/sh6.06 P/B5.07 EPS next Y10.37% ROA9.30% Target Price32.74 Perf Year18.98%
Cash/sh7.16 P/C4.29 EPS next 5Y7.42% ROE27.60% 52W Range21.52 - 33.19 Perf YTD3.47%
Dividend- P/FCF13.10 EPS past 5Y3.30% ROI13.00% 52W High-7.44% Beta1.30
Dividend %- Quick Ratio2.60 Sales past 5Y-1.30% Gross Margin78.00% 52W Low42.75% ATR0.58
Employees11600 Current Ratio2.60 Sales Q/Q5.60% Oper. Margin26.40% RSI (14)61.24 Volatility1.84% 1.88%
OptionableYes Debt/Eq1.32 EPS Q/Q-17.60% Profit Margin20.30% Rel Volume1.29 Prev Close30.39
ShortableYes LT Debt/Eq1.11 EarningsJan 25 AMC Payout0.00% Avg Volume10.94M Price30.72
Recom2.50 SMA202.29% SMA505.00% SMA2009.27% Volume14,112,132 Change1.09%
Jan-03-17Resumed Piper Jaffray Neutral $28
Jan-03-17Initiated Aegis Capital Buy $36
Oct-21-16Upgrade Hilliard Lyons Long-term Buy → Buy
Oct-20-16Reiterated Wedbush Neutral $34 → $33
Oct-20-16Reiterated Mizuho Neutral $31 → $32
Oct-18-16Reiterated Monness Crespi & Hardt Buy $32 → $35
Oct-17-16Reiterated The Benchmark Company Buy $33 → $38
Oct-13-16Resumed Wedbush Neutral $34
Sep-29-16Upgrade Deutsche Bank Hold → Buy $30 → $40
Sep-14-16Reiterated Axiom Capital Buy $34 → $38
Sep-13-16Reiterated Axiom Capital Buy $34 → $38
Aug-30-16Initiated Hilliard Lyons Long-term Buy $35
Jul-21-16Reiterated The Benchmark Company Buy $29 → $33
Jul-21-16Reiterated RBC Capital Mkts Sector Perform $28 → $31
Jul-21-16Reiterated Monness Crespi & Hardt Buy $29 → $32
Jul-21-16Reiterated Mizuho Neutral $26 → $31
Jul-21-16Reiterated Canaccord Genuity Hold $27 → $28
Jul-21-16Reiterated Axiom Capital Buy $30 → $34
Jun-23-16Initiated Maxim Group Buy $36
Apr-27-16Reiterated RBC Capital Mkts Sector Perform $29 → $28
Jan-19-17 03:46PM  Better Buy: eBay Inc. vs. Overstock.com at Motley Fool
01:44PM  Costco Sells the Most Coveted Golf Ball at MarketWatch
11:17AM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of PayPal Holdings, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
Jan-18-17 05:20PM  Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of PayPal Holdings, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
09:31AM  eBay Isn't Worth Your Attention
08:57AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Business Wire
08:51AM  PayPal CEO Dan Schulman on the war against cash at CNBC
Jan-17-17 09:00PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In PayPal Holdings, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
04:49PM  Big Investment In LetGo Puts Pressure on eBay, Craigslist
11:16AM  Levi & Korsinsky Notifies Shareholders of a Complaint Filed in U.S. District Court to Recover Losses Suffered by Investors in PayPal (PYPL)
08:18AM  We will stand for our values in trade and immigration, eBay CEO Devin Wenig says at CNBC
07:50AM  EBay CEO: We are watching Trump's trade evolution
06:13AM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Accesswire
Jan-16-17 10:16AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PayPal Holdings, Inc. (PYPL) and eBay, Inc. (EBAY) and Lead Plaintiff Deadline - February 27, 2017 Accesswire
Jan-13-17 09:41PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., eBay Inc., and Encourages Investors With Losses to Contact the Firm Business Wire
09:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PayPal Holdings, Inc., eBay, Inc. of Class Action Lawsuit and Upcoming Deadline PYPL, EBAY GlobeNewswire
06:36PM  A Growth Plan for eBay: Buy Etsy at Barrons.com
04:46PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against PayPal Holdings, Inc., and eBay, Inc., and Encourages Investors with Losses to Contact the Firm Business Wire
12:23PM  PYPL EBAY LOSS ALERT: Rosen Law Firm Reminds PayPal Holdings, Inc. Investors of Deadline in Class Action Business Wire
Jan-12-17 04:16PM  eBay Has a New Plan to Eliminate Counterfeits at Investopedia
11:00AM  EBay Gets Hands-On in Fighting Fake Handbags With New Service
Jan-11-17 12:37PM  This Fund Will Try To Prevent Skynet From Actually Happening
06:56AM  Alibaba promises Trump itll create a million U.S. jobs, but dont believe it at MarketWatch
01:07AM  Traders see little downside in eBay
Jan-10-17 12:33PM  PYPL SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving PayPal Holdings, Inc. and a Lead Plaintiff Deadline of February 27, 2017 GlobeNewswire
10:13AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PayPal Holdings, Inc. (PYPL) and eBay, Inc. (EBAY) and Lead Plaintiff Deadline - February 27, 2017 Accesswire
09:40AM  Here's what Trump means for the tech industry at MarketWatch
Jan-09-17 08:45PM  [$$] How to Play the Next Big Alibaba Rally at Barrons.com
02:45PM  A Timeline of Every New iPhone Feature Apple Has Introduced in the Last 10 Years
12:40PM  There's Historic Demand For Tonight's National Championship Game Between Alabama And Clemson
09:00AM  Will Snap's Unique Marketing Strategies Change the Tech World in 2017?
08:21AM  Why Surging eBay Could Rip Even Higher
08:14AM  5 Rocket Stocks for 2017 -- Amgen, eBay, More
Jan-08-17 10:49AM  Why the Take Rate Is So Important in E-Commerce at Motley Fool
Jan-06-17 05:40PM  Adobe Should Shop for a Digital Commerce Platform: BMO Capital
04:49PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PayPal Holdings, Inc., eBay, Inc. of Class Action Lawsuit and Upcoming Deadline - PYPL, EBAY PR Newswire
11:19AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of PayPal Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 27, 2017 PYPL GlobeNewswire
10:22AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PayPal Holdings, Inc. (PYPL) and eBay, Inc. (EBAY) and Lead Plaintiff Deadline: February 27, 2017 Accesswire
Jan-05-17 05:48PM  Top Research Reports for J&J, Barclays and P&G
04:14PM  Amazon Wins Christmas, And Its 50-Day, As Macy's, Malls Mauled
04:00PM  eBay Partners With theSkimm To Make Selling Easier And More Meaningful In 2017 PR Newswire
04:00PM  eBay Partners With theSkimm To Make Selling Easier And More Meaningful In 2017 CNW Group
03:41PM  Amazon.com: Fulfillment by Amazon Sellers Are Thriving at Motley Fool
03:35PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In PayPal Holdings, Inc. (PYPL) And eBay, Inc. (EBAY) To Contact Brower Piven Before The L GlobeNewswire
Jan-04-17 05:50PM  Campbell-based eBay spinoff raises $250M as it looks to conquer Asia at bizjournals.com
08:11AM  [$$] Hillhouse invests $250m in US software provider at Financial Times
Jan-03-17 02:04PM  Here's how to sell those unwanted holiday gifts at CNBC
11:42AM  eBay Is A Rare Value Internet Stock With Growth Potential
11:15AM  One way Snapchat can evolve to beat back Instagram
10:51AM  Coverage initiated on eBay by Aegis Capital
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PayPal Holdings, Inc. (PYPL) & eBay, Inc. (EBAY) and Lead Plaintiff Deadline: February 27, 2017 GlobeNewswire
Dec-30-16 01:00PM  5 Tech Acquisitions That May Never Be Topped at Insider Monkey
11:35AM  Fake Law Enforcement Badges Still Available at eBay
12:12AM  [$$] Apple, eBay and Gold: We Called Them Right. We Missed Some, Too at The Wall Street Journal
Dec-29-16 11:38AM  [$$] Apple, eBay and Gold: We Called Them Right. We Missed Some, Too at The Wall Street Journal
10:08AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifes Investors of Class Action Against PayPal Holdings, Inc. (PYPL) and eBay, Inc. (EBAY) and Lead Plaintiff Deadline: February 27, 2017 Accesswire
08:15AM  Blog Coverage Alibaba's Entertainment Arm Plans to Invest More than Billions of Dollars in Next Three Years Accesswire
Dec-28-16 05:09PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifes Investors of Class Action Against PayPal Holdings, Inc. (PYPL) & eBay, Inc. (EBAY) and Lead Plaintiff Deadline: February 27, 2017 PR Newswire
04:06PM  Pomerantz Law Firm Announces the Filing of a Class Action against PayPal Holdings, Inc., eBay, Inc. and Certain Officers PYPL, EBAY GlobeNewswire
02:26PM  Where to sell your unwanted stuff online and earn extra cash
Dec-27-16 11:50AM  Will 2017 Be eBay Inc.'s Best Year Yet? at Motley Fool
11:20AM  Another sign that Amazon had a blockbuster holiday season at CNBC
10:59AM  Hatchimals, Barbie disappoint parents, kids on Christmas at CNBC
Dec-23-16 06:09PM  Trading In and Trading Up Proves Profitable for Winmark
Dec-22-16 11:10AM  AmerisourceBergen urges stockholders to reject unsolicited 'mini-tender' offer at bizjournals.com
09:01AM  Trumps Carlos Slim meeting brokered by Lewandowski | 62% of Democrats, independents say no to another Clinton run at MarketWatch
Dec-21-16 05:29PM  U.S. returns China's Taobao shopping website to market blacklist Reuters
12:33PM  Oracle Staffer Resigns, Starts Online Petition In Response To CEO Joining Trump Team
Dec-19-16 09:15AM  5 Rocket Stocks to Buy for a Santa Claus Rally: Facebook, Nike and More
Dec-17-16 05:20PM  Last-Minute Shoppers Could Drive Positive Holiday Sales
01:51PM  Ignore eBay Inc.: Here Are 2 Better Stocks at Motley Fool
10:10AM  10 Biggest Data Breaches of All Time at Insider Monkey
08:49AM  3 Numbers MercadoLibre Investors Should Be Watching at Motley Fool
Dec-16-16 05:21AM  Sports cant drain the swamp of political ties at MarketWatch
Dec-15-16 04:23PM  Vetr Crowd Bids On eBay While Holiday Sales Numbers Are Up In The Air
06:27AM  [$$] Quirk of '16 Holiday Calendar Promises a Crush in Web Sales at The Wall Street Journal
Dec-14-16 04:00PM  Buy These 5 Stocks Now Before It's Too Late
09:49AM  StubHub Releases Second Annual Year in Live Events Report: In a Year of Canadian Sports Team Wins and Notable Music Tours, Consumers Are Spending More Than Ever on Live Event Experiences Business Wire
09:03AM  StubHub Releases Second Annual Year in Live Events Report: In a Year of Firsts, Lasts and Milestone Events, Consumers Are Spending More Than Ever on Live Event Experiences Business Wire
Dec-13-16 10:30AM  eBay, Inc. Value Analysis (NASDAQ:EBAY) : December 13, 2016
Dec-12-16 01:49PM  Better Buy: eBay Inc. vs. Amazon at Motley Fool
01:28PM  [$$] High Court Sidesteps Fight on Online Sales Tax Rules at The Wall Street Journal
11:50AM  Alibaba Plans to Win Over Southeast Asia Through More than Just Acquisitions
11:01AM  Green Monday Is a Stale Holiday Shopping Leftover
09:18AM  EBay And Amazon Dominate The DIY Auto Retail Market
07:13AM  eBay, Inc. breached its 50 day moving average in a Bullish Manner : EBAY-US : December 12, 2016
Dec-11-16 02:39PM  5 Trade Ideas for Monday: Bristol-Myers, eBay, IBM, Nasdaq and Och-Ziff
Dec-09-16 04:59PM  This woman spent over $23,000 on toys
03:22PM  5 Best Stocks In The S&P 500 Index According To This Billionaire at Insider Monkey
Dec-08-16 10:30PM  Banking from the Shadows: Does the Texas banking industry discourage undocumented customers? The answer might surprise you at bizjournals.com
01:02PM  Stocks Trade At Record Highs; Fiber-Optic Stocks On Fire
08:00AM  Billionaire Stephen Mandel Ditches PayPal for eBay, Priceline for Expedia at Insider Monkey
Dec-07-16 03:26PM  Amazon Is Sued By Makers Of Snuggies Blankets at Investopedia
02:36PM  [video]Trump Invites Tech Executives to Break Bread at a Roundtable
07:50AM  Counterfeit Items Plague Amazon, eBay Holiday Shoppers at 24/7 Wall St.
Dec-06-16 02:54PM  Want to cash in on the Hatchimal craze? You are too late at CNBC
01:40PM  eBay's Technology Initiatives Should Drive Revenues at Forbes
Dec-05-16 03:00AM  Holiday Sales May Be Not So Merry for Retailers (AMZN, WMT) at Investopedia
Dec-02-16 05:09PM  Neiman Marcus Debenture Bonds Yielding 8%
eBay Inc. operates e-commerce platforms that connect various buyers and sellers worldwide. Its platforms enable sellers to organize and offer inventory for sale; and buyers to find and buy it virtually anytime and anywhere. The company's Marketplace platforms include its online marketplace at ebay.com and the eBay mobile apps; and StubHub platforms comprise its online ticket platform at stubhub.com and the StubHub mobile apps, which enable fans to purchase tickets to the games, concerts, and theater shows. Its Classifieds platforms include a collection of brands, such as Mobile.de, Kijiji, Gumtree, Marktplaats, eBay Classifieds, and others that offer online classifieds and help people find whatever they are looking for in their local communities. The company platforms enable users to find, buy, sell, and pay for items through various online, mobile, and offline channels, which include retailers, distributors, liquidators, import and export companies, auctioneers, catalog and mail-order companies, classifieds, directories, search engines, commerce participants, shopping channels, and networks. eBay Inc. was founded in 1995 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yetto Kristin ASVP, Chief People OfficerDec 15Option Exercise0.003,126023,966Dec 16 07:57 PM
FISHER STEPHENSVP, CTODec 15Option Exercise0.007,294093,552Dec 16 07:51 PM
WENIG DEVINPresident and CEODec 15Option Exercise0.0013,0860472,666Dec 16 07:47 PM
Schenkel Scott F.Chief Financial OfficerDec 15Option Exercise0.006,2520104,017Dec 19 07:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerDec 15Option Exercise0.00137,6430169,703Dec 19 07:38 PM
Lee Jae HyunSVP, Asia PacificDec 15Option Exercise0.003,126091,222Dec 19 07:32 PM
Doerger Brian J.VP, Chief Accounting OfficerDec 15Option Exercise0.0018,487045,313Dec 19 07:28 PM
Lawton III Harry ASVP, North AmericaDec 15Option Exercise0.003,647029,824Dec 19 07:23 PM
Huber Marie OhSVP, GC and SecretaryDec 15Option Exercise0.002,501022,079Dec 19 07:17 PM
Todd Jeremy PaulSVP, EMEADec 15Option Exercise0.002,084069,233Dec 19 07:09 PM
Doerger Brian J.VP, Chief Accounting OfficerNov 21Option Exercise22.8818,000411,87644,826Nov 23 07:13 PM
Doerger Brian J.VP, Chief Accounting OfficerNov 21Sale28.9318,000520,79626,826Nov 23 07:13 PM
Green LoganDirectorNov 02Buy28.321,00028,3211,000Nov 03 08:02 PM
FISHER STEPHENSVP, CTOOct 25Option Exercise21.6412,408268,532120,563Oct 26 07:50 PM
FISHER STEPHENSVP, CTOOct 25Sale29.2039,7641,161,10986,258Oct 26 07:50 PM
FISHER STEPHENSVP, CTOOct 15Option Exercise0.00106,5490169,212Oct 17 06:42 PM
Schenkel Scott F.SVP, Chief Financial OfficerOct 15Option Exercise0.005,9070100,848Oct 17 06:37 PM
WENIG DEVINPresident and CEOOct 15Option Exercise0.0013,8980466,832Oct 17 06:32 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerSep 15Option Exercise0.005,731035,051Sep 19 05:54 PM
Lee Jae HyunSVP, Asia PacificSep 15Option Exercise0.003,126088,096Sep 19 05:49 PM
Lawton III Harry ASVP, North AmericaSep 15Option Exercise0.003,647028,081Sep 19 05:44 PM
Huber Marie OhSVP, GC and SecretarySep 15Option Exercise0.002,500020,883Sep 19 05:32 PM
FISHER STEPHENSVP, CTOSep 15Option Exercise0.007,294066,470Sep 19 05:22 PM
Doerger Brian J.VP, Chief Accounting OfficerSep 15Option Exercise0.004,558029,205Sep 19 05:16 PM
Yetto Kristin ASVP, Chief People OfficerSep 15Option Exercise0.003,126022,472Sep 19 06:23 PM
Todd Jeremy PaulSVP, EMEASep 15Option Exercise0.002,084068,280Sep 19 06:06 PM
Schenkel Scott F.SVP, Chief Financial OfficerSep 15Option Exercise0.006,252098,204Sep 19 06:00 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerAug 31Option Exercise22.7141,880951,13948,779Sep 01 05:49 PM
Lee Jae HyunSVP, Asia PacificAug 31Sale31.8516,559527,42684,970Sep 02 04:58 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerAug 31Sale32.1439,0301,254,56526,980Sep 01 05:49 PM
SWAN ROBERT HOLMESDirectorAug 30Sale31.9550,0001,597,500375,928Sep 01 05:27 PM
Lee Jae HyunSVP, Asia PacificAug 24Sale31.025,625174,488101,529Aug 26 06:40 PM
Todd Jeremy PaulSVP, EMEAAug 10Option Exercise0.0032,935084,065Aug 12 05:06 PM
Lee Jae HyunSVP, Asia PacificJul 27Sale31.533,222101,590107,154Jul 28 08:15 PM
Lee Jae HyunSVP, Asia PacificJul 26Sale31.0310,601328,949110,376Jul 27 06:40 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 25Option Exercise22.6313,608307,94948,605Jul 27 06:19 PM
FISHER STEPHENSVP, CTOJul 25Option Exercise21.6437,223805,57797,032Jul 27 06:58 PM
TIERNEY THOMAS JDirectorJul 25Option Exercise9.858,00078,80025,545Jul 27 07:13 PM
TIERNEY THOMAS JDirectorJul 25Sale30.658,000245,20017,545Jul 27 07:13 PM
SWAN ROBERT HOLMESDirectorJul 25Sale30.6550,0001,532,340425,288Jul 27 07:06 PM
FISHER STEPHENSVP, CTOJul 25Sale30.6553,3891,636,16959,176Jul 27 06:58 PM
Lee Jae HyunSVP, Asia PacificJul 25Sale30.741,16735,878120,977Jul 27 06:40 PM
Yetto Kristin ASVP, Chief People OfficerJul 25Sale30.7917,596541,83419,346Jul 27 06:34 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 25Sale30.5623,958732,26424,647Jul 27 06:19 PM
Schenkel Scott F.SVP, Chief Financial OfficerJul 17Option Exercise0.001,768092,875Jul 18 08:27 PM
WENIG DEVINPresident and CEOJul 17Option Exercise0.005,8950449,754Jul 18 07:55 PM
Lawton III Harry ASVP, N.A.Jun 15Option Exercise0.0042,723039,075Jun 17 07:57 PM
Lee Jae HyunSVP, Asia PacificJun 15Option Exercise0.003,1270122,144Jun 17 07:53 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerJun 15Option Exercise0.005,732029,461Jun 17 07:50 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 15Option Exercise0.004,559037,376Jun 17 07:46 PM
Todd Jeremy PaulSVP, EMEAJun 15Option Exercise0.0014,501057,098Jun 17 07:42 PM
WENIG DEVINPresident and CEOJun 15Option Exercise0.0013,0870450,688Jun 17 08:18 PM
Schenkel Scott F.SVP, Chief Financial OfficerJun 15Option Exercise0.006,253094,370Jun 17 08:15 PM
Huber Marie OhSVP, GC & SecretaryJun 15Option Exercise0.0031,556029,055Jun 17 08:10 PM
Yetto Kristin ASVP, Chief People OfficerJun 15Option Exercise0.0015,543041,926Jun 17 08:04 PM
FISHER STEPHENSVP, CTOJun 15Option Exercise0.007,295079,149Jun 16 08:42 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 08Option Exercise0.0011,388038,760Jun 09 05:22 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMay 27Sale24.2425,000605,89823,729Jun 01 04:28 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 24Option Exercise16.6814,474241,42641,846May 24 08:58 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 24Sale24.0814,474348,53427,372May 24 08:58 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 09Option Exercise16.6820,000333,60047,372May 10 07:49 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 09Sale24.0320,000480,65027,372May 10 07:49 PM
Yetto Kristin ASVP, Chief People OfficerApr 29Sale24.1110,630256,30428,343May 03 07:29 PM
Yetto Kristin ASVP, Chief People OfficerApr 01Option Exercise0.0027,861052,553Apr 05 08:01 PM
WENIG DEVINPresident and CEOApr 01Option Exercise0.0078,0130477,120Apr 05 07:59 PM
Todd Jeremy PaulSVP, EMEAApr 01Option Exercise0.0017,168052,659Apr 05 07:49 PM
Schenkel Scott F.SVP, Chief Financial OfficerApr 01Option Exercise0.0025,0330100,013Apr 05 07:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerApr 01Option Exercise0.0010,973053,026Apr 05 07:47 PM
Lee Jae HyunSVP, Asia PacificApr 01Option Exercise0.0016,1830117,850Apr 05 07:36 PM
FISHER STEPHENSVP, CTOApr 01Option Exercise0.0010,919077,552Apr 05 07:35 PM
Doerger Brian J.VP, Chief Accounting OfficerApr 01Option Exercise0.0025,327036,892Apr 05 07:33 PM
PITTMAN RAYMOND JSVP, Chief Product Officer,Feb 26Option Exercise20.9428,204590,592111,323Mar 01 06:53 PM
PITTMAN RAYMOND JSVP, Chief Product Officer,Feb 26Sale24.3378,5371,910,77232,786Mar 01 06:53 PM
TIERNEY THOMAS JDirectorFeb 17Option Exercise6.694,42429,59719,901Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 17Sale23.084,424102,10615,477Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 16Option Exercise6.693,57623,92319,053Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 16Sale23.003,57682,24815,477Feb 18 07:01 PM
PRESSLER PAUL SDirectorFeb 01Buy23.944,180100,05410,448Mar 04 08:16 PM
SWAN ROBERT HOLMESDirectorFeb 01Sale23.7450,0001,187,065474,469Feb 03 05:23 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E22.57 EPS (ttm)1.23 Insider Own0.10% Shs Outstand2.10B Perf Week1.24%
Market Cap58.05B Forward P/E19.46 EPS next Y1.42 Insider Trans0.19% Shs Float1.41B Perf Month6.51%
Income2.53B PEG3.98 EPS next Q0.33 Inst Own36.20% Short Float1.56% Perf Quarter2.37%
Sales22.70B P/S2.56 EPS this Y-14.40% Inst Trans0.22% Short Ratio4.15 Perf Half Y-6.33%
Book/sh10.40 P/B2.66 EPS next Y16.46% ROA5.00% Target Price32.04 Perf Year38.21%
Cash/sh0.03 P/C1016.69 EPS next 5Y5.67% ROE11.90% 52W Range19.00 - 30.10 Perf YTD2.33%
Dividend1.64 P/FCF- EPS past 5Y16.90% ROI8.30% 52W High-8.07% Beta0.91
Dividend %5.93% Quick Ratio0.50 Sales past 5Y-4.30% Gross Margin15.10% 52W Low45.63% ATR0.46
Employees6800 Current Ratio0.80 Sales Q/Q-6.10% Oper. Margin15.80% RSI (14)65.31 Volatility1.24% 1.58%
OptionableYes Debt/Eq1.10 EPS Q/Q-6.80% Profit Margin11.10% Rel Volume0.70 Prev Close27.68
ShortableYes LT Debt/Eq0.97 EarningsJan 30 BMO Payout129.20% Avg Volume5.32M Price27.67
Recom1.60 SMA202.15% SMA505.98% SMA2002.86% Volume3,728,428 Change-0.04%
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
May-02-14Reiterated RBC Capital Mkts Outperform $71 → $80
May-02-14Reiterated Oppenheimer Outperform $74 → $86
Jan-19-17 09:45AM  Plains All American to boost capacity on Permian Basin to Corpus Christi pipeline at bizjournals.com
Jan-18-17 07:47PM  Cramer: The yield on this stock could go down on disappointing Kinder Morgan numbers at CNBC
05:20PM  Tech, Energy and Financial Stocks Are Set to Reap Highest Returns for Investors in 2017
03:35PM  Williams Partners Got Upgrade after Financial Repositioning
Jan-17-17 10:48AM  Which Midstream Stocks Have the Highest Implied Volatility?
Jan-13-17 08:54AM  Why You Should (and Shouldn't) Buy Enterprise Products Partners L.P. at Motley Fool
Jan-10-17 03:38PM  Williams Announces Major Financial Repositioning
10:37AM  What Are Analysts Recommending for Enbridge?
10:19AM  Rice Midstream Sees a Sudden Rise in Implied Volatility
Jan-09-17 01:17PM  Will Kinder Morgan Report Higher 4Q16 Earnings?
12:21PM  Is Enterprise Products Setting Up for a Breakout? at Investopedia
10:38AM  DCP Midstream Partners to Become US Largest NGLs Producer
10:37AM  Which MLPs Look Attractive for 2017?
09:06AM  How Does TC PipeLines Valuation Compare to Its Peers?
08:55AM  Enterprise Products Partners to Participate in UBS MLP One-on-One Conference Business Wire
07:36AM  Why Institutional Investors Seem Bullish on MLPs in 2017
Jan-08-17 09:25AM  3 Oil Stocks to Buy in January at Motley Fool
08:11AM  Top Oil Stocks to Buy in 2017 at Motley Fool
08:04AM  Top Gas Stocks to Buy in 2017 at Motley Fool
Jan-06-17 02:35PM  High Leverage Remained a Concern for MLPs in 2016
10:55AM  7 Dividend Stocks to Put on Your Shopping List at Motley Fool
09:09AM  Enterprise Products (EPD) Hikes Quarterly Distribution
07:45AM  7 MLP Giants That Keep Raising Distributions, Even Through Recent Hard Times
Jan-05-17 04:30PM  DryShips Inc.'s Stock Got Absolutely Pulverized in 2016, But the Worst May Be Over at Motley Fool
08:54AM  Enterprise Declares Quarterly Distribution Increase Business Wire
Jan-04-17 02:36PM  Kelley: Still deals to be made in oil sector
11:42AM  Why High Implied Volatility Midstream Stocks Move More Sharply
06:31AM  Tax repatriation favors mid-cap stocks: Pro
Jan-03-17 10:05AM  Stifel Select List Energy MLPs to Buy for 2017
Dec-30-16 10:35AM  How Does Shell Midstream Partnerss Valuation Compare with Its Peers?
07:38AM  Could ETE Further Simplify Its Organizational Structure in 2017?
Dec-28-16 07:35AM  How Many Analysts Are Rating Enterprise Products Partners a Buy?
Dec-27-16 02:43PM  Summit Midstream Partners Is RBC Capitals Top Pick for 2017
12:06PM  Bullish and Bearish Reversals in the Market
10:36AM  What Do the Valuations of EPD, PAA, WPZ, and MMP Indicate?
09:06AM  A Key Metric Comparison of Four Master Limited Partnerships
07:35AM  Whats Happening with Short Interest in Plains All American Pipeline?
Dec-26-16 10:36AM  Which Master Limited Partnerships Are Institutional Investors Buying?
09:06AM  Magellan Midstream Continues to Invest in Capital Projects
07:37AM  Which MLP Giant Has the Highest Leverage?
Dec-24-16 08:58PM  This Oil MLP Will Stuff Your Stocking With a 6% Yield
Dec-23-16 04:35PM  How EPD, MMP Offered Stable Distribution Growth in Tough Times
03:05PM  Inside the Distributable Cash Flow Growth of Four MLP Giants
01:08PM  Why Plains All American Pipeline Outperformed Peers in 2016
Dec-22-16 07:36AM  How US Ethane Exports Could Pick Up alongside Natural Gas Exports
01:00AM  U.S. refiners cash in on Mexico's record fuel imports Reuters
Dec-21-16 10:18AM  Analyzing Midstream Stocks Returns and Implied Volatility
07:36AM  Forget Kinder Morgan, Inc.: Here Are 3 Better Dividend Stocks at Motley Fool
Dec-20-16 10:35AM  Enterprise Products Partners: Is the Worst Over?
10:07AM  2 Dividend Stocks to Stay Away From -- and 1 Worth Buying at Motley Fool
09:05AM  What Short Interest in Enterprise Products Partners Stock Means
07:35AM  Are Institutional Investors Selling Their EPD Holdings?
Dec-19-16 12:20PM  Enterprise Products Partners LP : EPD-US: Dividend Analysis : October 31st, 2016 (record date) : By the numbers : December 19, 2016
10:35AM  Enterprise Products Partners Valuation: What Does It Mean?
09:05AM  Likely Additions to Oil Supply: Tailwind for Enterprise Products?
07:35AM  Why Enterprise Products Partners Leverage Isnt a Concern
Dec-16-16 03:52PM  8 MLP Picks for 2017 from RBC at Barrons.com
10:36AM  What Will Drive Enterprise Products Partners Growth?
09:06AM  Enterprise Products Partners: Taking the Organic Growth Route
07:36AM  Enterprise Products Partners: A Key Player in US LPG Exports
06:04AM  These 5 Big Stocks Could Be Turning 'Toxic'
Dec-15-16 05:05PM  Forget Vanguard Natural Resources, LLC: These 3 Stocks Are Better Buys at Motley Fool
03:35PM  Enterprise Products Gas Gathering, Processing: Contributing Less
02:05PM  Which Segment Drives Enterprise Products Partners Performance?
12:28PM  Whats Ahead for Enterprise Products Partners Stock in 2017?
11:40AM  Enterprise Products Partners LP Value Analysis (NYSE:EPD) : December 15, 2016
10:30AM  Enterprise Resumes Service at Pascagoula Natural Gas Processing Plant Business Wire
Dec-14-16 07:32AM  Enterprise Products Partners LP breached its 50 day moving average in a Bullish Manner : EPD-US : December 14, 2016
Dec-13-16 08:15AM  How Do Midstream Stocks Returns Affect Implied Volatility?
Dec-12-16 10:50PM  No Breakout for Enterprise Products on OPEC News at Investopedia
Dec-11-16 11:49AM  3 Safe Stocks You Can Buy Right Now at Motley Fool
Dec-09-16 04:35PM  KYN and TYG: MLP Investing through Mutual Funds
04:05PM  Whats Driving Williams Companies Recent Operating Performance?
03:05PM  Analyzing Top MLP Stocks Long-Term Performance
01:19PM  EPD, WPZ, and PAA: How Top MLPs Performed in 2016
Dec-08-16 08:55PM  Is Enterprise Products Partners Ready to Drop? at Investopedia
Dec-07-16 08:05AM  The Word on the Street: What Analysts Are Saying about Kinder Morgan
Dec-06-16 02:52PM  Enterprise Products Bouncing Up and Down (EPD) at Investopedia
12:26PM  Which Volatile Midstream Stocks Have Been Moving Lately?
Dec-05-16 09:21AM  4 winning investment moves for the Trump tax era at CNBC
08:55AM  Enterprise Products Partners to Present at Wells Fargo Pipeline, MLP and Utility Symposium Business Wire
Dec-04-16 05:06PM  The Secret Behind Enterprise's Falling Price (EPD) at Investopedia
05:37AM  5 Dividend Stocks to Buy in December at Motley Fool
Dec-02-16 03:04PM  Analyzing the Recent Trends in MLP Equity Issuance
02:40PM  Enterprise Did Not Respond Well to OPEC News (EPD) at Investopedia
Dec-01-16 05:51PM  More and More Hedge Funds Love Enterprise Products Partners L.P. (EPD) at Insider Monkey
Nov-30-16 10:17AM  Which Energy Company Is the Best Dividend Stock? at Motley Fool
08:04AM  What Does the MLP Funds Market Look Like?
Nov-28-16 10:50AM  3 High-Yield Dividend Stocks for Retirement at Kiplinger
Nov-26-16 06:03PM  Enterprise Dips Despite Strong Fundamentals (EPD) at Investopedia
08:45AM  Oil Rig Count Rises by 3; OPEC Supply Cut Talks Flounder
Nov-25-16 12:59PM  First Trust MLP and Energy Income Fund Announces Monthly Dividend
Nov-24-16 02:58PM  Enterprise Products Partners L.P. (EPD): How Safe Is This High-Yield MLPs Distribution? at Insider Monkey
Nov-23-16 10:30AM  How Do Midstream Stocks with Higher Implied Volatility Move?
08:19AM  EPD: A Good Company with Dangerous Stock Chart (EPD) at Investopedia
Nov-22-16 04:04PM  Why ETP Decided to Merge into Sunoco Logistics Partners
09:09AM  Analyzing US Crude Oil Movement by Rail in August
08:04AM  Capital Projects Should Continue to Drive ONEOKs Growth in 2017
Nov-19-16 08:10PM  Weekly Top Insider Buys Highlight for Week of Nov. 18
Nov-18-16 08:04AM  Dominion Midstream Targets Annual Distribution Growth of 22%
Enterprise Products Partners L.P., a master limited partnership, provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,500 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas export terminal and NGL import facility. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 478 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,100 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 674 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates refined products pipelines of approximately 4,200 miles; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
BARTH CARIN MARCYDirectorFeb 12Buy20.525,000102,6005,000Feb 17 04:06 PM
MCMAHEN CHARLES EDirectorFeb 12Buy19.9910,000199,90097,554Feb 12 04:13 PM
Montgomery William CDirectorFeb 11Buy19.6910,000196,90036,500Feb 11 06:48 PM
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-6.49 Insider Own2.30% Shs Outstand347.83M Perf Week-2.80%
Market Cap5.18B Forward P/E2.86 EPS next Y5.21 Insider Trans-30.24% Shs Float332.27M Perf Month5.67%
Income-2256.30M PEG- EPS next Q1.22 Inst Own66.80% Short Float8.75% Perf Quarter-32.49%
Sales10.01B P/S0.52 EPS this Y-133.00% Inst Trans20.21% Short Ratio1.52 Perf Half Y-39.36%
Book/sh11.92 P/B1.25 EPS next Y-4.14% ROA-4.70% Target Price24.08 Perf Year-83.32%
Cash/sh1.89 P/C7.87 EPS next 5Y11.07% ROE-42.90% 52W Range13.00 - 101.40 Perf YTD2.62%
Dividend- P/FCF13.35 EPS past 5Y4.40% ROI3.70% 52W High-85.31% Beta-0.16
Dividend %- Quick Ratio1.10 Sales past 5Y54.60% Gross Margin73.80% 52W Low14.62% ATR0.75
Employees22000 Current Ratio1.50 Sales Q/Q-11.00% Oper. Margin-5.20% RSI (14)44.34 Volatility3.97% 4.74%
OptionableYes Debt/Eq7.31 EPS Q/Q- Profit Margin-22.50% Rel Volume0.50 Prev Close15.11
ShortableYes LT Debt/Eq7.29 EarningsFeb 07 BMO Payout- Avg Volume19.17M Price14.90
Recom3.00 SMA20-0.40% SMA50-5.99% SMA200-37.13% Volume9,495,325 Change-1.39%
Jan-04-17Reiterated Piper Jaffray Underweight $16 → $11
Dec-15-16Downgrade Morgan Stanley Overweight → Equal-Weight $25 → $17
Nov-23-16Downgrade Mizuho Neutral → Underperform $25 → $11
Nov-14-16Reiterated Deutsche Bank Hold $29 → $24
Nov-10-16Reiterated Morgan Stanley Overweight $42 → $25
Nov-10-16Downgrade Rodman & Renshaw Buy → Neutral $81 → $23
Nov-09-16Reiterated RBC Capital Mkts Sector Perform $35 → $29
Oct-14-16Reiterated Deutsche Bank Hold $30 → $29
Oct-12-16Reiterated RBC Capital Mkts Sector Perform $36 → $35
Sep-20-16Resumed Deutsche Bank Hold $30
Aug-17-16Upgrade Morgan Stanley Equal-Weight → Overweight $33 → $42
Aug-15-16Upgrade Mizuho Underperform → Neutral $11 → $25
Aug-10-16Reiterated RBC Capital Mkts Sector Perform $31 → $36
Aug-10-16Reiterated Piper Jaffray Underweight $19 → $22
Aug-09-16Reiterated Rodman & Renshaw Buy $90 → $81
Jun-23-16Downgrade JP Morgan Overweight → Neutral
Jun-08-16Reiterated Stifel Buy $65 → $55
Jun-08-16Reiterated RBC Capital Mkts Sector Perform $58 → $33
Jun-08-16Reiterated Mizuho Underperform $18 → $11
May-03-16Reiterated Rodman & Renshaw Buy $105 → $102
Jan-18-17 04:27PM  Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids at The Wall Street Journal
Jan-17-17 06:19PM  Short Sellers Now Fleeing Valeant Stock at Investopedia
05:49PM  [$$] Allergan Admits to Disclosure Violations During Valeant Bid at The Wall Street Journal
04:44PM  Bill Ackman Eases Into the New Year at Investopedia
07:37AM  Mario Gabelli on Viacom: Potential Growth in the Media Sector
Jan-13-17 04:39PM  Will This Be a Genius or Foolish Move for Johnson & Johnson? at Motley Fool
10:33AM  The strange deal 2 drug makers had over a medicine with a skyrocketing price
06:02AM  Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News
Jan-12-17 02:35PM  ETFs with exposure to Valeant Pharmaceuticals International, Inc. : January 12, 2017
11:33AM  Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Back From The Dead? at Insider Monkey
10:19AM  Valeant Pharmaceuticals International, Inc. Value Analysis (NYSE:VRX) : January 12, 2017
09:37AM  12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies at Insider Monkey
07:35AM  Trump criticism leads to falling stock prices at these Tampa employers at bizjournals.com
07:15AM  Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
Jan-11-17 04:54PM  Valeant Pharmaceuticals: Separating Fact From Fiction at Motley Fool -6.52%
04:42PM  Valeant Streamlines Portfolio with Skincare Brands Sale
04:21PM  Drug Stocks Tank As Trump Vows To Attack High Drug Prices
03:22PM  Wednesdays Top Biopharma Movers
02:51PM  Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different
12:40PM  Valeant Pharmaceuticals: Now Comes the Hard Part at Barrons.com
10:15AM  Valeant Pharmaceuticals: 'A Long Road to Recovery' at Barrons.com
09:30AM  Latest Research Reports on Market Movers Valeant Pharmaceuticals and Chipotle Mexican Grill Accesswire
08:40AM  Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?
08:15AM  Blog Coverage Valeant Sells-Off Its Skin Care Brands to L'Oreal Accesswire
07:41AM  This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time at Motley Fool
07:30AM  Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bullish Manner : VRX-US : January 11, 2017
06:25AM  Valeant Soars 14% on $2.12B Worth of Asset Sales at Investopedia
12:07AM  [$$] LOréal Looks to Gain U.S. Share by Buying Valeant Brands at The Wall Street Journal
Jan-10-17 06:15PM  Celebrate One Debacle of a Merger With Another -- ICYMI +6.84%
05:11PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition
05:08PM  Valeant Sells $2.1 Billion in Assets to Ease Debt Burden
05:06PM  'Valeant Sale One of Many That Need to Get Done'
04:55PM  Nasdaq closes at 4th straight recordmarks best such streak since 1999 at MarketWatch
04:49PM  CANADA STOCKS-TSX rises with financials and materials; Valeant jumps
04:21PM  Jaguar Animal Health, Inc. (NAS:JAGX) Given Company Update by Aegis Capital Corp. ABN Newswire
04:08PM  CANADA STOCKS-TSX rises with financials and materials groups
03:30PM  Tuesdays Top Biopharma Movers
03:05PM  Valeant lessens debt load with billion-dollar L'Oréal deal at bizjournals.com
02:07PM  Valeant: A Solid Price? at Barrons.com
02:06PM  Valeant Pharmaceuticals International, Inc -- Moody's: Valeant asset sales credit positive at Moody's
01:40PM  Will This Cure What Ails Valeant Pharmaceuticals? at Motley Fool
01:14PM  [$$] Valeant: on the rebound at Financial Times
12:38PM  Valeant Gets Breathing Room But Little Else at Bloomberg
12:32PM  Here's What Valeant Could Still Divest
12:20PM  Markets Look to Trump's News Conference
12:11PM  Why Valeant Pharmaceuticals Stock Is Jumping Today at Motley Fool
11:43AM  Charts of the day: Valeant shares jump, Chipotle climbs on sales trend
11:12AM  Valeant's Asset Sale To L'Oreal Explained
11:05AM  Why Valeant Is Making a Run
10:44AM  Valeant Turns Assets to Cash With $2.1 Billion in Deals
10:44AM  Valeant Turns Assets to Cash With $2.1 Billion in Deals at Bloomberg
10:41AM  Top Biotech Resolutions for 2017 at Motley Fool
10:31AM  Valeant: A Good Start? at Barrons.com
10:24AM  CANADA STOCKS-TSX rises with materials stocks; Valeant jumps
10:16AM  Valeant unloads more assets, Goldman Sachs gets downgraded, Yahoo changes coming
10:12AM  Stocks Mixed; Why Are Illumina, Valeant, Barracuda Soaring?
10:09AM  L'Oreal Buys Skincare Lines From Valeant for $1.3 Billion -- and Jim Cramer Comments
09:49AM  Valeant to Sell Dendreon Unit to Sanpower for $820 Million
09:49AM  Valeant Stock Gains on Possible Salix Interest at Investopedia
09:28AM  [$$] L'Oréal Looks to Gain U.S. Share by Buying Valeant Brands at The Wall Street Journal
09:19AM  Stocks to Watch: Yahoo, Chipotle, Valeant at The Wall Street Journal
08:38AM  3 Tempting Stocks We're Avoiding at Motley Fool
08:14AM  Small businesses feel great, dealmaking on a tear and World Cup growth
07:59AM  Valeant sells $2B in assets to begin paying down debt
07:51AM  Early movers: YHOO, VRX, CUDA, UNH, BABA, JNJ, GS & more at CNBC
07:11AM  L'Oreal's Pricey Problem Solvers at Bloomberg
06:57AM  [$$] Valeant raises $2.1bn through asset sales at Financial Times
06:00AM  Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118 PR Newswire
06:00AM  Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118 CNW Group
06:00AM  Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA® For Presbyopia Contact Lenses PR Newswire
06:00AM  Bausch + Lomb Launches Expanded Parameters For Bausch + Lomb ULTRA® For Presbyopia Contact Lenses CNW Group
03:17AM  Valeant To Sell CeraVe, AcneFree And AMBI Skincare Brands To L'Oreal For $1.3 Billion PR Newswire
03:17AM  Valeant To Sell CeraVe, AcneFree And AMBI Skincare Brands To L'Oreal For $1.3 Billion CNW Group
02:46AM  Valeant to Sell $2.1 Billion in Assets to Pay Down Debt at Bloomberg
01:02AM  [$$] Valeant Agrees to Sell Dendreon to Sanpower for $820 Million at The Wall Street Journal
12:08AM  Valeant To Sell Dendreon Cancer Business To China's Sanpower For $820 Million Cash at Barrons.com
Jan-09-17 11:45PM  Valeant to sell Dendreon unit to China's Sanpower for $820 mln Reuters
11:29PM  [$$] Valeant Agrees to Sell Dendreon to Sanpower for $820 Million at The Wall Street Journal
10:58PM  Valeant to sell Dendreon unit to China's Sanpower for $819.9 mln
10:54PM  Valeant to sell its Dendreon cancer business to China's Sanpower at MarketWatch
10:40PM  Valeant To Sell Dendreon To Sanpower Group For $819.9 Million In Cash PR Newswire
10:40PM  Valeant To Sell Dendreon To Sanpower Group For $819.9 Million In Cash CNW Group
04:58PM  Valeant hiked prices for a dizzying number of drugs last week
12:51PM  Why Valeant Stock Rose 5.5% Last Week at Investopedia
Jan-08-17 02:13PM  What If You Considered Gilead Sciences a Start-Up? at Motley Fool
Jan-07-17 04:20PM  5 Destroyed Stocks That Could Be Major Buys In 2017
Jan-06-17 01:59PM  The Biggest Hedge Fund Failures of 2016 at Investopedia
10:22AM  The Laundry List of Reasons Why Valeant Pharmaceuticals Intl. Inc. Plummeted 86% in 2016 at Motley Fool
Jan-05-17 10:30AM  Six Happenings You Won't Want to miss when 'Frisco Takes Center Stage in Healthcare
Jan-04-17 05:03PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial
04:30PM  Valeant Pharmaceuticals To Present At The 35th Annual J.P. Morgan Healthcare Conference PR Newswire
04:30PM  Valeant Pharmaceuticals To Present At The 35th Annual J.P. Morgan Healthcare Conference CNW Group
04:21PM  How Trump-related uncertainty is bringing out the health-care stock bears at MarketWatch
04:05PM  Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors PR Newswire
04:05PM  Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors CNW Group
01:00PM  Health Care Stocks With Short-term Upside (AGN) at Investopedia
10:18AM  Valeant: Here's Why Piper Says It's Not Investable at Barrons.com
10:06AM  Jim Cramer -- Valeant Has Too Much Debt
Jan-03-17 07:01PM  Cramer: Reviewing S&P's Hit-and-Miss Parade
04:24PM  Valeant Pharmaceuticals Intl. Inc.'s Biggest Catalysts in 2017 at Motley Fool
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications. Further, it provides Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Metronidazole to treat bacterial infections; and Latanoprost for the treatment of glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September, 2010. The company was founded in 1983 and is based in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ross Thomas W. Sr.DirectorDec 14Buy14.735,00073,65026,822Dec 16 04:19 PM
Pershing Square Capital ManageDirectorDec 12Sale14.853,476,69051,628,84718,114,432Dec 13 04:14 PM
KARABELAS ARGERIS NDirectorAug 11Buy24.654,00098,60020,726Aug 12 04:37 PM
Ross Thomas W. Sr.DirectorJun 13Buy24.404,00097,60021,882Jun 27 03:40 PM
PAPA JOSEPH CCHAIRMAN & CEOJun 10Buy24.48202,0004,944,9602,442,199Jun 13 06:47 AM
LYB LyondellBasell Industries N.V. daily Stock Chart
LYB [NYSE]
LyondellBasell Industries N.V.
IndexS&P 500 P/E10.04 EPS (ttm)8.94 Insider Own18.58% Shs Outstand407.02M Perf Week1.49%
Market Cap36.53B Forward P/E9.13 EPS next Y9.83 Insider Trans0.00% Shs Float328.43M Perf Month1.22%
Income3.87B PEG- EPS next Q2.20 Inst Own73.90% Short Float3.03% Perf Quarter13.06%
Sales28.51B P/S1.28 EPS this Y20.00% Inst Trans0.09% Short Ratio3.45 Perf Half Y14.05%
Book/sh14.73 P/B6.09 EPS next Y5.36% ROA16.60% Target Price92.30 Perf Year27.92%
Cash/sh4.50 P/C19.96 EPS next 5Y-1.75% ROE61.20% 52W Range67.03 - 92.68 Perf YTD4.64%
Dividend3.40 P/FCF24.39 EPS past 5Y-11.60% ROI30.00% 52W High-3.15% Beta1.03
Dividend %3.79% Quick Ratio1.30 Sales past 5Y-4.50% Gross Margin20.80% 52W Low33.91% ATR1.52
Employees13000 Current Ratio2.20 Sales Q/Q-11.60% Oper. Margin17.90% RSI (14)61.28 Volatility1.49% 1.63%
OptionableYes Debt/Eq1.49 EPS Q/Q-10.20% Profit Margin13.60% Rel Volume0.72 Prev Close90.05
ShortableYes LT Debt/Eq1.39 EarningsFeb 03 BMO Payout36.40% Avg Volume2.88M Price89.76
Recom2.60 SMA202.08% SMA503.91% SMA20011.10% Volume2,078,570 Change-0.32%
Dec-29-16Reiterated Cowen Market Perform $87 → $90
Oct-14-16Initiated Tudor Pickering Buy
Sep-13-16Reiterated Deutsche Bank Hold $80 → $83
Jun-27-16Downgrade RBC Capital Mkts Outperform → Sector Perform $100 → $84
Jun-23-16Downgrade JP Morgan Overweight → Neutral $100 → $80
Jun-13-16Downgrade Cowen Outperform → Market Perform $105 → $87
Apr-27-16Downgrade Nomura Buy → Neutral
Apr-05-16Downgrade Atlantic Equities Neutral → Underweight
Feb-03-16Downgrade RBC Capital Mkts Top Pick → Outperform $105 → $95
Jan-11-16Downgrade Credit Agricole Outperform → Underperform
Nov-25-15Reiterated Cowen Outperform $98 → $105
Oct-12-15Downgrade Macquarie Outperform → Neutral
Sep-17-15Reiterated Deutsche Bank Hold $100 → $95
Sep-11-15Initiated Bernstein Outperform $110
Sep-01-15Reiterated Cowen Outperform $115 → $98
May-08-15Initiated Standpoint Research Buy
Apr-28-15Reiterated RBC Capital Mkts Top Pick $111 → $123
Apr-27-15Reiterated Jefferies Hold $85 → $99
Apr-27-15Reiterated Deutsche Bank Hold $96 → $105
Apr-27-15Reiterated Barclays Overweight $105 → $115
Jan-19-17 10:02AM  Top Ranked Growth Stocks to Buy for January 19th
09:30AM  The Zacks Analyst Blog Highlights: Kronos Worldwide, Ingevity, LyondellBasell Industries NV, Celanese Corporation and Albemarle
06:45AM  LyondellBasell Corpus Christi Complex Expansion Complete PR Newswire
Jan-18-17 05:27PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an
05:00PM  LyondellBasell announces planned leadership changes PR Newswire
03:29PM  5 Chemical Growth Stocks to Enrich Your Portfolio in 2017
Jan-13-17 04:06PM  LyondellBasell Donation to Provide Specialized Training for Six Houston-Area Fire Departments PR Newswire
09:11AM  Has DuPonts Stock Performance Retreated?
Jan-10-17 12:10PM  10 Best Stocks for Retired Investors at Kiplinger
08:15AM  Post Earnings Coverage as RPM Sales Up 3%, Earnings Dropped 5.5% Accesswire
Jan-09-17 07:36AM  How Is Dow Chemical Valued Compared to Its Peers?
Jan-06-17 09:07AM  Dow Chemical Stock: The Rapid Surge in December
Jan-05-17 03:50PM  LyondellBasell to keep Houston refinery at bizjournals.com
Jan-04-17 04:36PM  Solvay Has High Ebitda Margins and Is Paying Down Debt
06:49AM  LyondellBasell (LYB) Well Poised on Expansion Actions
Dec-30-16 08:15AM  Blog Coverage PPG Sells the Plaka Business to Knauf Accesswire
Dec-22-16 01:00AM  U.S. refiners cash in on Mexico's record fuel imports Reuters
Dec-21-16 12:35PM  Analyzing Air Products and Chemicalss Dividend Yield and Payout
Dec-19-16 07:36AM  Why Does LyondellBasell Keep Trading at a Discount?
Dec-17-16 05:13PM  How TransCanada Corporation (USA) (TRP) Stacks Up Against Similarly Valued Stocks at Insider Monkey
Dec-16-16 02:05PM  The Word on the Street: What Analysts Are Recommending for LyondellBasell
12:35PM  How Much Has LyondellBasell Been Rewarding Its Shareholders?
10:58AM  Could LyondellBasell Stock Be Making a Comeback?
Dec-13-16 04:42PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Change in Directors or Principal Officers
02:05PM  Heres the Latest from Analysts on Praxair
12:22PM  Why LyondellBasell and Huntsman Jumped More Than 10% in November at Motley Fool
09:00AM  Walmart Launches Online Destination for Last-Minute Shoppers
Dec-07-16 05:11PM  Chemicals Industry Stock Outlook - Dec 2016
09:36AM  Snapshot of Dow Chemicals Growth Opportunity in Saudi Arabia
Dec-03-16 03:03PM  The Best Plastic Stocks to Buy Today at Motley Fool
Nov-29-16 04:13AM  2 chemical stocks to buy and 2 to sell at MarketWatch
02:25AM  LyondellBasell Industries NV (LYB): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-28-16 01:34PM  Positives and Negatives of LyondellBasells 3Q16 Earnings
07:51AM  4 Blue Chip Stocks to Buy as Trump Rally Rages On
Nov-21-16 01:04PM  LyondellBasell Declares 4Q Dividend of $0.85
Nov-18-16 06:45AM  LyondellBasell Board Authorizes Interim Dividend PR Newswire
Nov-17-16 12:00PM  LyondellBasell to Address Citi's Basic Materials Conference PR Newswire
11:19AM  Polish Basell Orlen declares force majeure on some products
Nov-16-16 11:13AM  Andreas Halvorsen's Top 3 New Holdings
Nov-14-16 01:50PM  Two Chemicals Stocks Expected To Surge Under Trump Administration at Forbes
Nov-08-16 08:04AM  Lower Oil Prices Affect LYBs Refining Segments 3Q16 Earnings
Nov-07-16 04:06PM  A Quick Look at a Few Chemical Companies in 2016
11:04AM  What Do Analysts Think of LyondellBasell after Its 3Q16 Earnings?
10:04AM  How LYBs Intermediates & Derivatives Segment Performed in 3Q16
08:06AM  Why LYBs Olefins & Polyolefins EAI Segment Saw Higher Earnings
Nov-05-16 01:04PM  LYONDELLBASELL INDUSTRIES N.V. Financials
Nov-04-16 05:04PM  How LYBs Olefins & Polyolefins Americas Segment Did in 3Q16
03:04PM  Why Did LyondellBasells 3Q16 Earnings Miss Estimates?
01:13PM  Planned Maintenance Continues to Weigh Heavily on LyondellBasell
Nov-03-16 12:15PM  ETFs with exposure to LyondellBasell Industries NV : November 3, 2016
Nov-02-16 06:00PM  LyondellBasell to Address Morgan Stanley Global Chemicals and Agriculture Conference PR Newswire
09:44AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016
08:33AM  LyondellBasell Industries NV breached its 50 day moving average in a Bearish Manner : LYB-US : November 2, 2016
Nov-01-16 06:40PM  Edited Transcript of LYB earnings conference call or presentation 1-Nov-16 3:00pm GMT
11:04AM  Why Did DuPonts Electronics and Communications Segment Revenue Decline in 3Q16?
11:02AM  [$$] LyondellBasell Results Hurt by Operating Disruptions at The Wall Street Journal
10:12AM  LyondellBasell (LYB) Beats on Q3 Earnings and Revenues
10:04AM  DuPonts Protection Solutions Revenue in 3Q16 Remained Flat amid Higher Volumes
08:39AM  LyondellBasell (LYB) Q3 Earnings and Sales Beat Estimates
08:02AM  Will LyondellBasell (LYB) Stock Be Hurt by Q3 Miss?
07:58AM  LyondellBasell beats Street 3Q forecasts
07:07AM  Q3 2016 LyondellBasell Industries NV Earnings Release - Before Market Open
06:47AM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
06:45AM  LyondellBasell Reports Third-Quarter 2016 Earnings PR Newswire
Oct-31-16 11:46AM  [$$] Just how LBI went bust is subject to legal controversy at Financial Times
11:25AM  What to Watch When LyondellBasell (LYB) Reports Q3 Earnings
11:03AM  3 Reasons Value Stock Investors Will Love LyondellBasell (LYB)
09:47AM  Why Earnings Season Could Be Great for LyondellBasell (LYB)
08:53AM  Chemical Stocks Q3 Earnings Slated on Nov 1: LYB, ECL, TSE
Oct-28-16 08:16AM  CVR Partners (UAN) Q3 Loss Wider than Expected, Sales Lag
07:37AM  LyondellBasell (LYB) Q3 Earnings: A Beat in the Cards?
Oct-27-16 11:04AM  Why Is LyondellBasell Trading at a Discount to Its Peers?
10:05AM  Why Wall Street Analysts Are Cautious on LyondellBasell
09:30AM  Zacks.com featured highlights: LyondellBasell Industries N.V., Citrix Systems, Boston Scientific, Broadcom and ConAgra Foods
08:05AM  Why Do Analysts Expect Lower 3Q16 Margins for LyondellBasell?
Oct-26-16 06:04PM  Can LyondellBasell Beat 3Q16 Estimates amid Its Maintenance Woes?
04:27PM  Will LyondellBasells Stock Continue to Recover in 4Q16?
09:47AM  What's behind calls in LyondellBasell
08:05AM  5 Top ROE Picks as Q3 Earnings Bells Chime
Oct-21-16 05:48PM  [$$] Len Blavatnik Defends Boom-Era Merger of LyondellBasell at The Wall Street Journal
03:48PM  Blavatnik Says $22 Billion LyondellBasell Merger Was Worth It
Oct-19-16 03:46PM  Lyondell Hearing Raises Ghosts Of Ill-Fated Debt-Laden Merger at Forbes
Oct-17-16 05:54PM  [$$] Trial Begins in Lyondell Clawback Lawsuit at The Wall Street Journal
07:30AM  LyondellBasell to Discuss Third-Quarter Results on Tuesday, November 1, 2016 PR Newswire
Oct-14-16 06:03AM  Coverage initiated on LyondellBasell by Tudor Pickering
Oct-13-16 04:02PM  Be Aware of These Low P/S Stocks
Oct-12-16 11:17AM  LyondellBasell Industries NV : LYB-US: Dividend Analysis : August 16th, 2016 (record date) : By the numbers : October 12, 2016
Oct-11-16 09:15AM  Here's Why These 2 Top Chemical Stocks Are Strong Buys Right Now
Oct-07-16 08:42AM  Is LyondellBasell Industries (LYB) Stock a Solid Choice Right Now?
Oct-06-16 09:30AM  Zacks.com featured highlights: Cooper Tire & Rubber, Ultra Petroleum, LyondellBasell Industries N.V., Apogee Enterprises and Summit Materials
08:51AM  3 Reasons Why LyondellBasell (LYB) is a Great Value Stock
Oct-05-16 08:44AM  5 Efficient Stocks That Promise Impressive Returns
Sep-26-16 05:52PM  Jefferies Announces an Upward Revision of LyondellBasells Price Target
Sep-22-16 05:36PM  LyondellBasell (LYB) Stock Price Target Raised at Jefferies
Sep-21-16 11:36AM  LyondellBasell Industries NV Value Analysis (NYSE:LYB) : September 21, 2016
Sep-20-16 08:17AM  LyondellBasell Industries NV breached its 50 day moving average in a Bullish Manner : LYB-US : September 20, 2016
Sep-19-16 06:22PM  Jeff Auxier Buys Biogen, LyondellBasell and Union Pacific
Sep-15-16 07:16AM  Several bullish trades in LyondellBasell
Sep-13-16 12:28AM  PRESS DIGEST- New York Times business news - Sept 13 Reuters
Sep-12-16 07:20AM  LyondellBasell (LYB) to Build HDPE Plant at La Porte Complex
LyondellBasell Industries N.V. operates as a manufacturer of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers. The company operates in five segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Refining; and Technology. It produces and markets olefins, including ethylene, propylene, and butadiene; polyolefins, which consist of high density polyethylene, low density polyethylene, linear low density polyethylene, and polypropylene (PP); specialty polyolefins comprising PP compounds, catalloy process resins, and polybutene-1 resins; and aromatics, which include benzene. The company also produces and markets propylene oxide (PO); PO co-products, such as styrene monomers and tertiary butyl alcohol; PO derivatives consisting of propylene glycol, propylene glycol ethers, and butanediol; acetyls, including methanol, acetic acid, and vinyl acetate monomers; and ethylene derivatives, such as ethylene oxide, ethylene glycol, ethylene glycol ethers, and ethanol. In addition, it refines gasoline and components, ultra low sulfur diesel, jet fuel, lube oils, and aromatics. Further, the company develops and licenses chemical, polyolefin, and other process technologies, as well as provides associated engineering and other services; and develops, manufactures, and sells polyolefin catalysts. LyondellBasell Industries N.V. was founded in 2005 and is based in London, United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bindra Jagjeet S.DirectorAug 30Sale80.013,750300,0208,876Sep 01 09:17 AM
Covezzi MassimoSVP Research & DevelopmentApr 26Sale89.147,551673,1119,702Apr 26 04:28 PM
Vasnetsov SergeySVP Strategic PlanningApr 26Sale89.893,127281,0764,733Apr 26 04:28 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerMar 09Sale82.531,100,00090,786,41077,354Mar 10 04:38 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerMar 08Sale82.041,000,00082,042,77779,646Mar 10 04:38 PM
TMO Thermo Fisher Scientific Inc. daily Stock Chart
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E28.81 EPS (ttm)5.01 Insider Own0.10% Shs Outstand394.16M Perf Week-1.30%
Market Cap56.89B Forward P/E15.73 EPS next Y9.18 Insider Trans-19.88% Shs Float393.87M Perf Month1.25%
Income2.00B PEG2.58 EPS next Q2.39 Inst Own88.40% Short Float1.10% Perf Quarter-4.75%
Sales17.97B P/S3.16 EPS this Y4.60% Inst Trans0.05% Short Ratio2.14 Perf Half Y-8.29%
Book/sh54.87 P/B2.63 EPS next Y11.21% ROA- Target Price172.83 Perf Year8.92%
Cash/sh5.04 P/C28.66 EPS next 5Y11.15% ROE- 52W Range119.26 - 160.35 Perf YTD2.28%
Dividend0.60 P/FCF- EPS past 5Y15.00% ROI7.00% 52W High-10.00% Beta1.10
Dividend %0.42% Quick Ratio1.10 Sales past 5Y10.30% Gross Margin45.60% 52W Low21.02% ATR2.04
Employees52000 Current Ratio1.60 Sales Q/Q8.90% Oper. Margin- RSI (14)46.80 Volatility1.16% 1.32%
OptionableYes Debt/Eq0.87 EPS Q/Q0.40% Profit Margin- Rel Volume0.71 Prev Close144.66
ShortableYes LT Debt/Eq0.78 EarningsJan 31 BMO Payout- Avg Volume2.02M Price144.32
Recom1.70 SMA200.32% SMA50-0.32% SMA200-3.35% Volume1,435,915 Change-0.24%
Jan-18-17Initiated Deutsche Bank Buy $163
Nov-10-16Resumed Leerink Partners Outperform
Sep-22-16Resumed JP Morgan Overweight $180
Sep-09-16Downgrade Cleveland Research Buy → Neutral
May-27-16Reiterated Mizuho Buy $166 → $170
May-19-16Reiterated Mizuho Buy $163 → $166
May-03-16Reiterated Mizuho Buy $160 → $163
Apr-29-16Downgrade Jefferies Buy → Hold
Apr-04-16Reiterated Mizuho Buy $150 → $160
Mar-02-16Reiterated Topeka Capital Markets Buy $145 → $155
Jan-11-16Reiterated Stifel Buy $150 → $158
Jan-07-16Initiated Deutsche Bank Buy $160
Oct-06-15Initiated Argus Buy $145
Jul-23-15Reiterated Mizuho Buy $150 → $160
May-21-15Reiterated Barclays Overweight $160 → $165
Mar-10-15Initiated UBS Buy $160
Jan-21-15Reiterated Robert W. Baird Outperform $142 → $144
Aug-12-14Initiated Stifel Buy $150
Jan-30-14Reiterated Mizuho Buy $130 → $140
Jan-30-14Reiterated ISI Group Buy $121.50 → $130
Jan-19-17 08:34AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : January 19, 2017
Jan-18-17 03:54PM  Coverage initiated on Thermo Fisher by Deutsche Bank
07:40AM  Will Thermo Fisher (TMO) Beat Earnings Estimates in Q4?
Jan-13-17 04:02PM  Santoli: Market's been hard to rattle, but also hard to i...
10:38AM  Behind Johnson & Johnsons Recent Stock Performance
Jan-12-17 05:10PM  Trumps HHS nominee has promised to divest from these Mass. companies at bizjournals.com
Jan-06-17 11:05AM  Thermo Fisher Scientific, Inc. Value Analysis (NYSE:TMO) : January 6, 2017
09:00AM  Thermo Fisher Scientific to Hold Earnings Conference Call on Tuesday, January 31, 2017 Business Wire
Jan-05-17 08:24AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : January 5, 2017
Jan-04-17 06:05PM  Roberts recuses from patent case after discovering conflict
05:49PM  U.S. chief justice steps aside in patent case over stock conflict Reuters
Jan-03-17 08:30AM  Thermo Fisher Scientific to Present at 35th Annual J.P. Morgan Healthcare Conference on January 10, 2017 Business Wire
Jan-02-17 10:37AM  BD Lifesciencess Product Pipeline Could Boost Its Fiscal 2017 Growth
09:07AM  BD Lifesciencess Performance and Core Focus Areas
Dec-16-16 12:56PM  Billionaire Larry Robbins Knows How To Pick Mega-Cap Stocks at Insider Monkey
Dec-14-16 04:08PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Change in Directors or Principal Officers
11:08AM  Illumina Stock Now Worth a Lot Less? Here's What You Need to Know at Motley Fool
Dec-13-16 09:30AM  Zacks.com featured highlights: Arch Capital Group, NICE, First American Financial, Silicon Motion Technology and Thermo Fisher Scientific
Dec-12-16 07:23AM  5 GARP Stocks that Should Grace Your Portfolio
Dec-07-16 11:18AM  A Quick Review of Thermo Fisher
Dec-06-16 04:35PM  Cryder Capital Boosts Bets On Alphabet (GOOG), Credit Cards, Health Stocks at Insider Monkey
07:20AM  Supreme Court case involving Thermo Fisher could affect big manufacturers at bizjournals.com
Dec-03-16 07:43PM  5 Capital Goods Stocks Hedge Funds Were Dumping in Q3 at Insider Monkey
Dec-02-16 02:46PM  MedTech Sails Through Macro Woes: Stocks in Focus
08:05AM  Boston Scientific Completes Its Acquisition of EndoChoice
Dec-01-16 10:05AM  Baxter Makes Significant Advancements in Hemodialysis Treatments
08:05AM  How Baxter Continues to Contribute to Patient Care
Nov-30-16 05:02PM  A Growth Stock in the Land of Value Stocks?
10:48AM  What Are Analysts Recommendations for Thermo Fisher Scientific?
10:48AM  TMO Creates Shareholder Value through Strong Capital Allocation
10:48AM  How Is Thermo Fisher Scientifics FEI Integration Process Going?
10:48AM  How Is Thermo Fisher Scientific Accelerating Growth?
10:48AM  How Has Thermo Fisher Scientifics Stock Performed Recently?
Nov-28-16 02:57PM  Battle of Bulls and Bears Lies Ahead for Thermo Fisher
09:30AM  Zacks.com featured highlights: First American Financial, AngioDynamics, Microsemi, Thermo Fisher Scientific and F5 Networks
07:41AM  Is Thermo Fisher Scientific Inc. (TMO) a Good Stock to Invest in? at Insider Monkey
Nov-25-16 08:18AM  5 GARP Stocks to Benefit from Trump Induced Rebound
Nov-23-16 12:21PM  Eli Lilly & Juno Therapeutics plummet after failed drug t...
Nov-21-16 11:04AM  Exploring the Nuances of Strykers Cost Transformation for Growth
10:04AM  How Is Stryker Moving Forward with International Growth?
08:04AM  How Are Strykers Core Strategies Working Toward Its Growth?
Nov-18-16 04:37PM  What Are Analysts Latest Recommendations for Stryker?
Nov-15-16 09:31AM  Thermo Fisher Scientific Inc. (TMO), HCA Holdings Inc (HCA) & Two More: Should You Follow Cryder Capital Into Its Top Picks? at Insider Monkey
Nov-13-16 04:45PM  Thermo Fisher shares could rise 30 pct over the next 2 years -Barron's
Nov-12-16 12:01AM  [$$] Thermo Fisher Has 30% Upside at Barrons.com
Nov-11-16 06:04PM  What Were Becton Dickinsons 4Q16 Growth Drivers?
Nov-10-16 04:30PM  Thermo Fisher Scientific Declares Quarterly Dividend Business Wire
01:04PM  THERMO FISHER SCIENTIFIC INC. Financials
09:30AM  The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Arch Capital Group, IPG Photonics, AngioDynamics and Express Scripts Holding
Nov-09-16 09:00AM  5 GARP Stocks to Buy Now
07:28AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : November 9, 2016
Nov-08-16 08:30AM  Thermo Fisher Scientific and Hamilton Storage Partner to Simplify Sample Storage Business Wire
Nov-05-16 12:13PM  The Unsung Heroes of CAR-T at Motley Fool
Nov-04-16 12:12PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 10-Q, Quarterly Report
10:00AM  How to Position Before the Presidential Election
08:15AM  Blog Coverage VWR Corporation Announces Two Acquisitions Accesswire
Nov-02-16 08:06AM  Thermo Fisher Scientific Updated Its 2016 Guidance
Nov-01-16 11:06AM  Analyzing Thermo Fisher Scientifics Recent Stock Performance
10:07AM  Highlights from Thermo Fisher Scientifics 3Q16 Earnings
08:46AM  5 Top Stocks with Imposing Earnings Growth
08:07AM  Analysts Recommendations for Thermo Fisher Scientific
Oct-31-16 02:13PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : October 31, 2016
Oct-28-16 09:29AM  Thermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: Q3, 2016 By the Numbers : October 28, 2016
09:21AM  7 Dividend Stocks That Promise Stability and Growth
08:30AM  Thermo Fisher Scientific to Present at Bairds 2016 Industrial Conference on November 8, 2016 Business Wire
Oct-27-16 04:51PM  Edited Transcript of TMO earnings conference call or presentation 27-Oct-16 12:30pm GMT
11:30AM  [$$] Thermo Fisher Scientific Lifts Outlook at The Wall Street Journal
09:33AM  Thermo Fisher (TMO) Tops Q3 Earnings, Raises '16 Outlook
08:10AM  Thermo Fisher Scientific (TMO): Tops Q3 Earnings and Revenue
07:32AM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:07AM  Q3 2016 Thermo Fisher Scientific Inc Earnings Release - Before Market Open
06:08AM  Thermo Fisher beats Street 3Q forecasts
06:00AM  Thermo Fisher raises 2016 revenue, earnings forecasts
06:00AM  Thermo Fisher Scientific Reports Third Quarter 2016 Results Business Wire
Oct-26-16 10:00AM  Can Thermo Fisher (TMO) Pull a Surprise in Q3 Earnings?
09:39AM  Analysts Recommendations ahead of BDXs Fiscal 4Q16 Earnings
09:30AM  Zacks.com featured highlights: AngioDynamics, Luxoft Holding, Boston Scientific, Popeyes Louisiana Kitchen and Thermo Fisher Scientific
08:20AM  Medical Instrument Earnings Slated on Oct 27: TMO, ABMD, TFX
Oct-25-16 09:42AM  5 GARP Stocks Well Positioned to Provide Impressive Yields
Oct-21-16 12:46PM  Time Out's CEO says its $1.9 million YPlan acquisition is all about selling happiness
08:41AM  Clinton's Odds of Winning Presidency High: Top 5 Picks
Oct-20-16 08:30AM  Thermo Fisher Scientific Partners with Boys & Girls Clubs of America to Bring STEM Education to the Next Generation of Employees and Leaders Business Wire
06:00AM  'Mad Money' Lightning Round: Stick With AMN Healthcare
Oct-19-16 07:02PM  Cramer: Move over H&R Block, this tax play is taking the world by storm at CNBC
12:56PM  What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers
Oct-18-16 09:30AM  Zacks.com featured highlights: Lennox International, Spectrum Brands Holdings, ULTA Salon, Cosmetics & Fragrance, ONE Gas and Thermo Fisher Scientific
Oct-17-16 04:30PM  Thermo Fisher Scientific Joins Cancer Moonshot Effort Business Wire
12:04PM  Analyzing Abbott Laboratories 3Q16 Revenue Estimates
07:30AM  White House To Announce Big Push For Cancer Blood Tests at Forbes
07:07AM  Q3 Earnings May Not be as Dreary: 5 Solid Picks
Oct-15-16 08:12AM  Thermo Fisher's Handheld Drug Analyzer, Other Products Make It a Good Investment
Oct-14-16 12:31PM  The Zacks Analyst Blog Highlights: Caterpillar, Microsoft, Thermo Fisher, Alcoa and PNC Financial
Oct-13-16 01:06PM  New Research Reports for Microsoft, Caterpillar & Thermo Fisher Zacks
12:24PM  BofA: Expect upside to Merck estimates
08:30AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : October 13, 2016
07:49AM  Thermo Fisher: Buyout Synergies on Track, Grows Globally
Oct-12-16 04:30PM  3 Warning Signs from Illumina, Inc.'s Q3 Preview at Motley Fool
Oct-05-16 04:51PM  Broadcom, Thermo Fisher, Stryker Top Thursday Investing Action Plan
12:38PM  Thermo Fisher Scientific, Inc. : TMO-US: Dividend Analysis : September 15th, 2016 (record date) : By the numbers : October 5, 2016
08:04AM  Analysts Strong Buy Recommendation for Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company's Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company's Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChief Executive OfficerSep 02Option Exercise54.9728,7971,582,971307,444Sep 06 04:52 PM
CASPER MARC NChief Executive OfficerSep 02Sale151.0128,7974,348,635278,647Sep 06 04:52 PM
CASPER MARC NChief Executive OfficerSep 01Option Exercise54.9730,0001,649,100308,647Sep 02 05:32 PM
CASPER MARC NChief Executive OfficerSep 01Sale151.1730,0004,535,076278,647Sep 02 05:32 PM
Shine Daniel PSenior Vice PresidentAug 29Sale152.281,699258,72417,437Aug 31 05:00 PM
Loewald Thomas WSenior Vice PresidentAug 29Sale152.283,256495,82435,814Aug 31 04:58 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 29Sale152.282,270345,67627,384Aug 31 04:56 PM
Shine Daniel PSenior Vice PresidentAug 26Sale151.7847672,24719,136Aug 30 05:20 PM
Loewald Thomas WSenior Vice PresidentAug 26Sale151.92913138,70339,070Aug 30 05:17 PM
CASPER MARC NChief Executive OfficerAug 15Sale155.9625,0003,899,031295,998Aug 17 04:54 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 10Sale156.005,023783,58831,914Aug 11 04:46 PM
HARRIS C MARTINDirectorAug 05Sale157.3339061,3594,648Aug 08 04:53 PM
Loewald Thomas WSenior Vice PresidentJul 13Option Exercise73.248,025587,75152,194Jul 14 04:35 PM
Loewald Thomas WSenior Vice PresidentJul 13Sale155.008,0251,243,87544,169Jul 14 04:35 PM
CASPER MARC NChief Executive OfficerJul 05Option Exercise54.9720,0001,099,400340,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 05Sale147.6920,0002,953,804320,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Option Exercise54.9730,0001,649,100350,998Jul 06 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Sale148.8530,0004,465,638320,998Jul 06 04:42 PM
Shine Daniel PSenior Vice PresidentJun 15Option Exercise54.976,900379,29328,779Jun 16 05:00 PM
Shine Daniel PSenior Vice PresidentJun 15Sale148.316,9001,023,35621,879Jun 16 05:00 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Option Exercise54.9768,2003,748,954138,777Jun 14 04:47 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Sale152.3868,20010,392,63370,577Jun 14 04:47 PM
MANZI JIM PDirectorJun 03Sale153.001,137173,96138,733Jun 06 04:41 PM
Loewald Thomas WSenior Vice PresidentJun 02Option Exercise73.2415,0001,098,60059,169Jun 06 04:39 PM
Loewald Thomas WSenior Vice PresidentJun 02Sale152.8415,0002,292,60044,169Jun 06 04:39 PM
Williamson StephenSr. VP and CFOMay 25Option Exercise54.973,740205,58833,821May 26 04:38 PM
Williamson StephenSr. VP and CFOMay 24Option Exercise54.978,660476,04038,741May 26 04:38 PM
Williamson StephenSr. VP and CFOMay 24Sale150.298,6601,301,48330,081May 26 04:38 PM
HORNSTRA PETER EVP & Chief Accounting OfficerMay 16Option Exercise68.386,357434,69425,671May 17 11:39 AM
HORNSTRA PETER EVP & Chief Accounting OfficerMay 16Sale150.007,8111,171,65017,860May 17 11:39 AM
Shine Daniel PSenior Vice PresidentApr 26Option Exercise54.975,000274,85027,892Apr 27 04:09 PM
Shine Daniel PSenior Vice PresidentApr 26Sale146.006,013877,89821,879Apr 27 04:09 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Apr 05Option Exercise73.2410,000732,40046,937Apr 07 04:28 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Apr 05Sale141.8610,0001,418,58036,937Apr 07 04:28 PM
Durbin Patrick MSenior Vice PresidentApr 04Option Exercise64.3911,250724,37944,348Apr 06 04:21 PM
Durbin Patrick MSenior Vice PresidentApr 04Sale142.1816,2502,310,42528,098Apr 06 04:21 PM
Williamson StephenSr. VP and CFOMar 22Option Exercise51.634,592237,07830,081Mar 23 04:36 PM
Williamson StephenSr. VP and CFOMar 21Option Exercise51.7510,708554,09536,197Mar 23 04:36 PM
Williamson StephenSr. VP and CFOMar 21Sale139.5010,7081,493,76625,489Mar 23 04:36 PM
CASPER MARC NChief Executive OfficerMar 14Sale139.2830,0004,178,296320,998Mar 16 05:40 PM
Malus Alan JExecutive Vice PresidentMar 10Option Exercise126.3925,9253,276,78873,211Mar 14 04:47 PM
Malus Alan JExecutive Vice PresidentMar 10Sale139.0525,9253,604,80947,286Mar 14 04:47 PM
Malus Alan JExecutive Vice PresidentMar 09Option Exercise73.2411,525844,09162,732Mar 11 04:07 PM
Malus Alan JExecutive Vice PresidentMar 09Sale138.5015,4462,139,29047,286Mar 11 04:07 PM
SPERLING SCOTT MDirectorMar 03Option Exercise36.8720,000737,40085,790Mar 07 04:31 PM
Loewald Thomas WSenior Vice PresidentMar 03Option Exercise49.493,625179,40147,794Mar 04 07:15 PM
Loewald Thomas WSenior Vice PresidentMar 03Sale137.283,625497,64044,169Mar 04 07:15 PM
SPERLING SCOTT MDirectorMar 03Sale137.905,350737,74580,440Mar 07 04:31 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Mar 01Sale135.002,951398,38536,937Mar 02 05:12 PM
Shine Daniel PSenior Vice PresidentFeb 29Sale130.2461479,96722,892Mar 02 04:50 PM
Shine Daniel PSenior Vice PresidentFeb 26Option Exercise54.975,000274,85030,089Mar 01 05:30 PM
Shine Daniel PSenior Vice PresidentFeb 26Sale131.006,180809,58023,909Mar 01 05:30 PM
Malus Alan JExecutive Vice PresidentFeb 01Option Exercise59.04103,4006,105,022149,221Feb 02 04:41 PM
Malus Alan JExecutive Vice PresidentFeb 01Sale130.24103,40013,467,21145,821Feb 02 04:41 PM
CRM salesforce.com, inc. daily Stock Chart
CRM [NYSE]
salesforce.com, inc.
IndexS&P 500 P/E257.04 EPS (ttm)0.29 Insider Own0.10% Shs Outstand692.74M Perf Week-0.26%
Market Cap52.35B Forward P/E58.76 EPS next Y1.29 Insider Trans-74.83% Shs Float658.74M Perf Month8.17%
Income205.60M PEG9.09 EPS next Q0.25 Inst Own84.20% Short Float2.22% Perf Quarter3.85%
Sales7.91B P/S6.62 EPS this Y83.00% Inst Trans-0.29% Short Ratio2.40 Perf Half Y-8.00%
Book/sh9.86 P/B7.66 EPS next Y31.36% ROA1.50% Target Price94.44 Perf Year7.45%
Cash/sh1.73 P/C43.60 EPS next 5Y28.28% ROE3.50% 52W Range52.60 - 84.48 Perf YTD10.39%
Dividend- P/FCF34.28 EPS past 5Y-21.10% ROI0.00% 52W High-10.55% Beta1.40
Dividend %- Quick Ratio0.60 Sales past 5Y32.10% Gross Margin74.10% 52W Low43.67% ATR1.30
Employees19000 Current Ratio0.60 Sales Q/Q25.30% Oper. Margin1.30% RSI (14)62.31 Volatility1.54% 1.67%
OptionableYes Debt/Eq0.37 EPS Q/Q-42.60% Profit Margin2.60% Rel Volume0.54 Prev Close75.78
ShortableYes LT Debt/Eq0.37 EarningsFeb 16 AMC Payout0.00% Avg Volume6.11M Price75.57
Recom1.80 SMA204.88% SMA504.11% SMA200-0.90% Volume3,274,106 Change-0.28%
Jan-12-17Downgrade Pivotal Research Group Buy → Hold $105 → $76
Jan-11-17Initiated Wells Fargo Outperform
Nov-18-16Reiterated Wedbush Outperform $96 → $98
Nov-18-16Reiterated Mizuho Buy $85 → $95
Nov-18-16Reiterated BMO Capital Markets Outperform $86 → $90
Oct-18-16Initiated Rosenblatt Buy $90
Sep-01-16Reiterated Wedbush Outperform $98 → $96
Sep-01-16Reiterated RBC Capital Mkts Outperform $91 → $85
Sep-01-16Reiterated Mizuho Buy $100 → $85
Sep-01-16Reiterated BMO Capital Markets Outperform $98 → $86
Jun-15-16Initiated BMO Capital Markets Outperform $98
May-19-16Reiterated Wunderlich Buy $93 → $101
May-19-16Reiterated Wedbush Outperform $95 → $98
May-19-16Reiterated Stifel Buy $85 → $93
May-19-16Reiterated MKM Partners Buy $86 → $96
May-19-16Reiterated Mizuho Buy $90 → $100
May-19-16Reiterated Canaccord Genuity Buy $88 → $95
May-19-16Reiterated Barclays Overweight $88 → $89
May-17-16Reiterated Jefferies Hold $60 → $74
May-12-16Reiterated Barclays Overweight $72 → $88
Jan-19-17 11:30PM  [$$] Tech leaders at Davos fret over effect of AI on jobs at Financial Times
06:58PM  Quip Acquires Unity and Variety
05:35PM  Why Salesforce Has to Be Ambitious in Revenue Growth at Market Realist
03:47PM  Salesforces Big Revenue Aims amid Struggling Peers
01:06PM  Marc Benioff: Most Popular Computer Today Is Mobile Phone
01:06PM  Marc Benioff: Most Popular Computer Today Is Mobile Phone at Bloomberg
11:22AM  Why the Salesforce-Amazon Web Services Partnership Makes Sense
08:15AM  Post Earnings Coverage as Progress Software Adjusted Earnings Up; Announced Approximately 20% Reduction in Workforce Accesswire
Jan-18-17 04:01PM  Salesforce Announces Grand Opening of New Seattle Area Engineering & Innovation Hub, Plans to Double Local Workforce to 500 PR Newswire
02:37PM  Salesforce CEO Marc Benioff sees a huge sales opportunity under Trump's administration Business Insider
11:17AM  [$$] Cloud Selloff Lets Through a Ray of Sun at The Wall Street Journal
Jan-17-17 02:36PM  Salesforce CEO: I'm not changing how I run my business under Trump
02:10PM  Exclusive: Salesforce media relations honcho decamps for major Google position at bizjournals.com
11:39AM  Wintry Davos More Like the Alamo This Year
10:40AM  10 Biggest Cloud Computing Companies in the World at Insider Monkey
10:08AM  Salesforce.com CEO Marc Benioff : 'Expect Us to Look at Anything That's Exciting' at TheStreet
08:31AM  CRM CEO: Looking for 'gems' that will allow us to grow
08:29AM  Salesforce, king of the cloud: CEO
Jan-16-17 04:47PM  Salesforce Chairman and CEO Marc Benioff to Participate in the World Economic Forum Annual Meeting 2017 PR Newswire
08:00AM  Salesforce Delivers '2017 Connected Banking Customer Report,' Exploring Expectations of Today's Digitally Savvy Banking Customers PR Newswire
Jan-15-17 03:21PM  Oracle's Strategy to Hit $10 Billion in SaaS Revenues
Jan-14-17 03:29PM  Insider Buys Highlight for Week of Jan. 13
Jan-13-17 07:37AM  Why Salesforce May Not Have Peace in 2017 at Market Realist
Jan-12-17 07:01PM  Cramer: If This Is a Sugar High, Sugar Sure Tastes Good
04:10PM  IBM Gets Price Target Hike, Skyworks Downgraded, Boeing Started Low
04:07PM  Salesforce.com And Small-Cap Twilio: Comeback Favorites
01:44PM  Salesforce's New Hire, Monica Langley, Might Help Company Land Its Next Major Acquisition
01:01PM  Monica Langley Joins Salesforce as EVP, Global Strategic Affairs PR Newswire
11:25AM  Salesforce Analyst Summit Recap: Why Salesforce Must Regroup To Reach Higher In 2017 at Forbes
08:42AM  Salesforce.com downgraded by Pivotal Research Group
07:36AM  Understanding Microsoft and Peers Growth Strategies at Market Realist
06:50AM  True Fit hires former Demandware exec as its e-retailer software takes off at bizjournals.com
Jan-11-17 05:05PM  Will Strategic Imperatives Again Rule IBMs 4Q16 Results?
03:48PM  Mark Cuban-backed Catalant adds Salesforce exec to drive growth at bizjournals.com
10:36AM  Why IBM and Peers Are Integrating Offerings
07:12AM  A software firm backed by Salesforce and Mark Zuckerbergs investment adviser heads for an IPO at CNBC
Jan-10-17 05:37PM  Salesforce will likely end its $5 billion buying spree this year, but its rivals won't Business Insider
12:33PM  Why Is Salesforce Stock Stuck? Gurufocus
Jan-09-17 04:55PM  Why Shares of ServiceNow Rose Last Week at Market Realist
04:30PM  Salesforce CFO and Executive Vice President to Participate in Upcoming Investor Events PR Newswire
10:34AM  Jim Cramer -- Salesforce Should Be Higher After Analyst Note at TheStreet
09:55AM  Cramer's Stop Trading: CRM
09:36AM  If Salesforce Shares Surge 35% Very Soon, This Will Be Why at TheStreet
Jan-06-17 07:01PM  Cramer: The Agriculture Cycle Has Turned; Watch AGCO and Deere Fly
03:55PM  [$$] Two Software Stock Dogs Ready to Run in 2017 at Barrons.com
10:15AM  salesforce.com, inc. Value Analysis (NYSE:CRM) : January 6, 2017
07:30AM  Salesforce President and Chief Product Officer to Participate in Upcoming Investor Event PR Newswire
Jan-05-17 11:43AM  Looking To Invest In The Cloud? 7 Stocks To Own In 2017
09:12AM  salesforce.com, inc. breached its 50 day moving average in a Bullish Manner : CRM-US : January 5, 2017
08:00AM  Salesforce Releases Second Annual State of Service Report, Uncovering Insights for The Future of Customer Service PR Newswire
Jan-04-17 07:01PM  Cramer: Skies Brightening for Cloud Group at TheStreet
05:36PM  Salesforce Praised, Two Media Names Enter Buy Range As Stocks Rise
04:25PM  Salesforce.com Stock Rallies In 2017 As Top Software Pick
02:20PM  Salesforce: Relax, Says Canaccord, Big M&A Is Unlikely at Barrons.com
12:16PM  Why Salesforce Investors Shouldn't Worry About Firm's Lack of Big M&A Deals at TheStreet
12:12PM  Investors Remain Concerned Salesforce Has Come Unglued
10:55AM  Why This Analyst Sees 2 Enterprise Software Players Doing Much Better in 2017 24/7 Wall St.
09:57AM  Shell Upgraded; Tesla, Apple, Priceline, Expedia Are Buys
09:36AM  Three Questions for Salesforce in 2017 (CRM) at Investopedia
07:33AM  Salesforce.com Is Poised for a Rebound at TheStreet
Jan-03-17 01:45PM  Year in Review: Salesforce.com Inc. (CRM) at Investopedia
10:36AM  A Look at the Artificial Intelligence Acquisition Spree in 2016
09:06AM  Why the Focus on Artificial Intelligence and Machine Learning?
Jan-02-17 01:39PM  The 2 Worst Artificial Intelligence Stocks of 2016 at Motley Fool
09:05AM  These Key Factors Will Drive M&A Trend for Oracle and Its Tech Peers
Dec-30-16 04:57PM  Salesforce.com A 'Software Behemoth,' Billings Mix Upside?
04:21PM  Apple, Salesforce, Twilio, Splunk Among Drexel's Top Stock Picks
03:21PM  Salesforce, Microsoft and Oracle in a 3-Way SaaS Engagement Gurufocus
12:31PM  Is Salesforce a Good Buy for 2017? at Motley Fool
12:30PM  Internet predictions for 2017: Pro
12:28PM  Stay with tech in 2017?
12:05PM  Why Salesforce is betting big on booming growth, as competition heats up at bizjournals.com
12:11AM  [$$] Salesforce Banks on Rapid Revenue Growth at The Wall Street Journal
Dec-29-16 11:52PM  [$$] Salesforce Banks on Rapid Revenue Growth at The Wall Street Journal
07:00AM  Technology: This Firm Is the Newest Software Empire at Morningstar
Dec-28-16 07:25PM  Twitter's 2016 Wild Timeline: A Year in Review at Investopedia
10:36AM  What Could Drive Oracles SaaS and PaaS Revenue Growth? at Market Realist
09:05AM  Why Oracles SaaS and PaaS Revenue Growth Is a Positive Sign at Market Realist
07:37AM  [$$] Twitter: flock and a hard place at Financial Times
07:19AM  Top tech plays in 2016
Dec-27-16 03:39PM  Four Trends In Customer Engagement In 2017 at Forbes
10:36AM  How Did Oracles Software Segment Perform in Fiscal 2Q17? at Market Realist
Dec-23-16 04:30PM  Salesforce Grants Equity Awards Under Its Inducement Equity Incentive Plan PR Newswire
10:55AM  [$$] Three Questions for Software in 2017 at Barrons.com
Dec-21-16 07:14PM  Can Salesforce (CRM) Stock Rebound to Start 2017?
04:44PM  Sense of the Markets: Software M&A Bargains Abound at TheStreet
04:43PM  Twilio Surges On Expanded Amazon Web Services Deal
09:20AM  5 Stocks Poised to Pop this Earnings Season
09:05AM  What Are Analysts Recommending for Oracle Stock? at Market Realist
08:20AM  RBC Has 5 Top Large Cap Software Picks for 2017 at 24/7 Wall St.
07:36AM  Adobes Increased Initiatives to Strengthen Its Marketing Cloud at Market Realist
05:03AM  Twitter is toast and the stock is not even worth $10: Analyst at CNBC
Dec-20-16 05:11PM  The roles of cloud computing and fog computing in the Internet of Things revolution
04:27PM  SaaS-y Salesforce, A 'Teenager' Next To Peers, Gets Buy Rating
02:44PM  Salesforce is in a better place than ever, analyst says at CNBC
01:04PM  Salesforce in a 'Remarkable Position,' Analyst Contends at TheStreet
12:56PM  Dow Guns For 20K; IBD 50 Financials Strong, Salesforce Sluggish
12:30PM  Making a Watch List, Checking It Twice at TheStreet
12:18PM  Drexel Hamilton: Salesforce has plenty of growth ahead
10:37AM  How Digital Marketing Contributed to Adobes Fiscal 4Q16 Results at Market Realist
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. It offers enterprise cloud computing applications and platform services, including Sales Cloud that enables companies to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices. The company also provides Service Cloud that enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud, which enables companies to plan, personalize, and optimize customer interactions. In addition, it offers Community Cloud that enables companies to engage with groups of people by giving them access to information, applications, and experts; Analytics Cloud, an application, which enables companies to deploy sales, service, marketing, and custom analytics applications using various data source; Internet of Things Cloud that enables customers to process data, as well as build personalized actions and engage with customers in real time; and App Cloud, an application development platform for companies to deliver connected applications for various business needs. Further, the company provides professional services, including consulting, deployment, training, and design and integration services to facilitate the adoption of its cloud solutions, as well as offers various education service offerings ranging from introductory online courses to advanced architecture certifications. It sells and markets services primarily through its direct sales force, as well as through consulting firms, systems integrators, and regional partners. The company has a strategic alliance with Cisco to develop IoT and contact center platforms. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Benioff MarcChairman of the Board and CEOJan 19Option Exercise39.0910,000390,92534,155,500Jan 19 07:23 PM
Benioff MarcChairman of the Board and CEOJan 19Sale75.6010,000756,02034,145,500Jan 19 07:23 PM
Roos John VictorDirectorJan 19Sale75.6514410,89417,924Jan 19 07:44 PM
Benioff MarcChairman of the Board and CEOJan 18Option Exercise39.0910,000390,92534,155,500Jan 18 07:54 PM
Benioff MarcChairman of the Board and CEOJan 18Sale75.6910,000756,89834,145,500Jan 18 07:54 PM
Benioff MarcChairman of the Board and CEOJan 17Option Exercise39.0910,000390,92534,155,500Jan 18 07:54 PM
Conway CraigDirectorJan 17Sale75.1925018,7989,243Jan 18 07:39 PM
Benioff MarcChairman of the Board and CEOJan 17Sale74.9410,000749,37734,145,500Jan 18 07:54 PM
Benioff MarcChairman of the Board and CEOJan 13Option Exercise39.0910,000390,92534,155,500Jan 13 07:52 PM
Benioff MarcChairman of the Board and CEOJan 13Sale75.4210,000754,20334,145,500Jan 13 07:52 PM
Benioff MarcChairman of the Board and CEOJan 12Option Exercise39.0910,000390,92534,155,500Jan 13 07:52 PM
Roos John VictorDirectorJan 12Sale75.1114410,81618,068Jan 13 07:35 PM
Benioff MarcChairman of the Board and CEOJan 12Sale74.8810,000748,82234,145,500Jan 13 07:52 PM
Benioff MarcChairman of the Board and CEOJan 11Option Exercise39.0910,000390,92534,155,500Jan 11 08:25 PM
Benioff MarcChairman of the Board and CEOJan 11Sale75.5410,000755,44234,145,500Jan 11 08:25 PM
Benioff MarcChairman of the Board and CEOJan 10Option Exercise39.0910,000390,92534,155,500Jan 10 08:37 PM
Benioff MarcChairman of the Board and CEOJan 10Sale73.8810,000738,79234,145,500Jan 10 08:37 PM
Benioff MarcChairman of the Board and CEOJan 09Option Exercise39.0910,000390,92534,155,500Jan 10 08:37 PM
Wojcicki SusanDirectorJan 09Buy73.861,35399,93721,356Jan 10 08:33 PM
Benioff MarcChairman of the Board and CEOJan 09Sale73.8510,000738,54534,145,500Jan 10 08:37 PM
Benioff MarcChairman of the Board and CEOJan 06Option Exercise39.0910,000390,92534,155,500Jan 10 08:37 PM
Benioff MarcChairman of the Board and CEOJan 06Sale73.4110,000734,07134,145,500Jan 10 08:37 PM
Benioff MarcChairman of the Board and CEOJan 05Option Exercise39.0910,000390,92534,155,500Jan 05 08:14 PM
Roos John VictorDirectorJan 05Sale72.8114410,48518,212Jan 05 08:11 PM
Benioff MarcChairman of the Board and CEOJan 05Sale73.1110,000731,09134,145,500Jan 05 08:14 PM
Benioff MarcChairman of the Board and CEOJan 04Option Exercise39.0910,000390,92534,155,500Jan 04 08:41 PM
Hawkins Mark JChief Financial OfficerJan 04Option Exercise59.6425,8741,543,12536,780Jan 04 08:49 PM
Benioff MarcChairman of the Board and CEOJan 04Sale72.2310,000722,34634,145,500Jan 04 08:41 PM
Hawkins Mark JChief Financial OfficerJan 04Sale72.0025,8741,862,92810,906Jan 04 08:49 PM
Benioff MarcChairman of the Board and CEOJan 03Option Exercise39.0910,000390,92534,155,500Jan 04 08:41 PM
Benioff MarcChairman of the Board and CEOJan 03Sale70.3110,000703,07034,145,500Jan 04 08:41 PM
Benioff MarcChairman of the Board and CEODec 30Sale68.6212,500857,73134,145,500Dec 30 06:06 PM
Benioff MarcChairman of the Board and CEODec 29Sale69.2612,500865,76634,158,000Dec 29 06:32 PM
Roos John VictorDirectorDec 29Sale68.801449,90719,426Dec 29 06:39 PM
Robbins Cynthia G.EVP, Global Employee SuccessDec 28Sale69.852,935205,010230Dec 28 06:48 PM
Benioff MarcChairman of the Board and CEODec 28Sale69.3312,500866,68334,170,500Dec 28 06:51 PM
Benioff MarcChairman of the Board and CEODec 27Sale69.9212,500873,97934,183,000Dec 28 06:51 PM
Benioff MarcChairman of the Board and CEODec 23Sale69.8112,500872,58134,195,500Dec 28 06:51 PM
Benioff MarcChairman of the Board and CEODec 22Sale69.7912,500872,37434,208,000Dec 22 07:17 PM
Roos John VictorDirectorDec 22Sale69.7814410,04819,570Dec 22 07:25 PM
Benioff MarcChairman of the Board and CEODec 21Sale69.8612,500873,30934,220,500Dec 21 08:19 PM
Benioff MarcChairman of the Board and CEODec 20Sale69.5712,500869,56834,233,000Dec 20 08:37 PM
Benioff MarcChairman of the Board and CEODec 19Sale69.6312,500870,32134,245,500Dec 20 08:37 PM
Benioff MarcChairman of the Board and CEODec 16Sale69.9712,500874,66334,408,000Dec 16 06:08 PM
Benioff MarcChairman of the Board and CEODec 15Sale70.7812,500884,78234,420,500Dec 15 07:59 PM
Conway CraigDirectorDec 15Sale71.311,10578,7989,493Dec 15 08:01 PM
Roos John VictorDirectorDec 15Sale71.3114410,26919,714Dec 15 08:04 PM
Benioff MarcChairman of the Board and CEODec 14Sale71.4512,500893,11434,433,000Dec 14 08:44 PM
Benioff MarcChairman of the Board and CEODec 13Sale71.6312,500895,41434,445,500Dec 13 08:20 PM
Dayon AlexandrePres. & Chief Product OfficerDec 12Sale70.762,159152,77021,551Dec 12 07:29 PM
Benioff MarcChairman of the Board and CEODec 12Sale70.0712,500875,87534,458,000Dec 12 07:38 PM
Dayon AlexandrePres. & Chief Product OfficerDec 10Option Exercise0.004,112023,710Dec 12 07:29 PM
Benioff MarcChairman of the Board and CEODec 09Sale71.3512,500891,83034,470,500Dec 12 07:38 PM
Benioff MarcChairman of the Board and CEODec 08Sale71.7912,500897,40134,483,000Dec 08 07:32 PM
Benioff MarcChairman of the Board and CEODec 07Sale71.0012,500887,45434,495,500Dec 07 08:21 PM
Benioff MarcChairman of the Board and CEODec 06Sale70.5312,500881,61634,508,000Dec 06 07:43 PM
Wojcicki SusanDirectorDec 05Buy69.291,44399,98720,003Dec 05 07:25 PM
Benioff MarcChairman of the Board and CEODec 05Sale70.6712,500883,32934,520,500Dec 05 07:20 PM
Benioff MarcChairman of the Board and CEODec 02Sale68.4312,500855,34234,533,000Dec 02 08:03 PM
Benioff MarcChairman of the Board and CEODec 01Sale69.5112,500868,89434,545,500Dec 01 08:13 PM
Benioff MarcChairman of the Board and CEONov 30Sale72.6112,500907,59334,558,000Nov 30 08:38 PM
Martinez MariaPres., Sales & Cust. SuccessNov 29Sale72.761,27993,06033,214Nov 30 08:32 PM
Allanson JoeChief Accounting OfficerNov 29Sale72.761,16584,76529,353Nov 30 08:34 PM
Benioff MarcChairman of the Board and CEONov 29Sale72.8412,500910,52834,570,500Nov 30 08:38 PM
Allanson JoeChief Accounting OfficerNov 28Sale73.031,31195,74330,518Nov 28 09:34 PM
Dayon AlexandrePres. & Chief Product OfficerNov 28Sale73.032,234163,15019,598Nov 28 09:36 PM
Norton Burke FEVP and Chief Legal OfficerNov 28Sale73.031,983144,82077,422Nov 28 09:38 PM
Martinez MariaPres., Sales & Cust. SuccessNov 28Sale73.033,335243,55734,493Nov 28 09:40 PM
Hawkins Mark JChief Financial OfficerNov 28Sale73.0399272,44610,906Nov 28 09:42 PM
Benioff MarcChairman of the Board and CEONov 28Sale72.9912,500912,40034,583,000Nov 28 06:23 PM
Weaver Amy EEVP, General CounselNov 28Sale73.031,03875,80615,698Nov 28 09:44 PM
Robbins Cynthia G.EVP, Global Employee SuccessNov 28Sale73.031,32696,8393,165Nov 28 09:48 PM
Harris ParkerCo-FounderNov 28Sale73.032,076151,61238,049Nov 28 09:58 PM
Allanson JoeChief Accounting OfficerNov 27Option Exercise0.001,484031,829Nov 28 09:34 PM
Norton Burke FEVP and Chief Legal OfficerNov 27Option Exercise0.001,152079,405Nov 28 09:38 PM
Martinez MariaPres., Sales & Cust. SuccessNov 27Option Exercise0.004,936037,828Nov 28 09:40 PM
Robbins Cynthia G.EVP, Global Employee SuccessNov 27Option Exercise0.0022004,491Nov 28 09:48 PM
Harris ParkerCo-FounderNov 27Option Exercise0.001,328040,125Nov 28 09:58 PM
Allanson JoeChief Accounting OfficerNov 26Option Exercise0.00452030,345Nov 28 09:34 PM
Dayon AlexandrePres. & Chief Product OfficerNov 26Option Exercise0.002,713021,832Nov 28 09:36 PM
Norton Burke FEVP and Chief Legal OfficerNov 26Option Exercise0.001,085078,253Nov 28 09:38 PM
Martinez MariaPres., Sales & Cust. SuccessNov 26Option Exercise0.00724032,892Nov 28 09:40 PM
Hawkins Mark JChief Financial OfficerNov 26Option Exercise0.001,876011,898Nov 28 09:42 PM
Weaver Amy EEVP, General CounselNov 26Option Exercise0.001,206016,736Nov 28 09:44 PM
Robbins Cynthia G.EVP, Global Employee SuccessNov 26Option Exercise0.001,20604,271Nov 28 09:48 PM
Harris ParkerCo-FounderNov 26Option Exercise0.001,085038,797Nov 28 09:58 PM
Allanson JoeChief Accounting OfficerNov 25Option Exercise0.00540029,893Nov 28 09:34 PM
Dayon AlexandrePres. & Chief Product OfficerNov 25Option Exercise0.001,512019,119Nov 28 09:36 PM
Norton Burke FEVP and Chief Legal OfficerNov 25Option Exercise0.001,512077,168Nov 28 09:38 PM
Martinez MariaPres., Sales & Cust. SuccessNov 25Option Exercise0.00648032,168Nov 28 09:40 PM
Weaver Amy EEVP, General CounselNov 25Option Exercise0.00756015,530Nov 28 09:44 PM
Robbins Cynthia G.EVP, Global Employee SuccessNov 25Option Exercise0.001,08003,065Nov 28 09:48 PM
Harris ParkerCo-FounderNov 25Option Exercise0.001,512037,712Nov 28 09:58 PM
Allanson JoeChief Accounting OfficerNov 25Sale73.7357742,54229,353Nov 28 04:56 PM
Benioff MarcChairman of the Board and CEONov 25Sale73.7512,500921,90534,595,500Nov 28 06:23 PM
Weaver Amy EEVP, General CounselNov 23Sale74.1232924,38714,774Nov 23 07:23 PM
Norton Burke FEVP and Chief Legal OfficerNov 23Sale74.121,971146,09875,656Nov 23 07:26 PM
Martinez MariaPres., Sales & Cust. SuccessNov 23Sale74.1298673,08631,520Nov 23 07:28 PM
Dayon AlexandrePres. & Chief Product OfficerNov 23Sale74.122,628194,79817,607Nov 23 07:34 PM
Allanson JoeChief Accounting OfficerNov 23Sale74.1265748,70029,930Nov 23 07:38 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-4.94 Insider Own0.10% Shs Outstand375.25M Perf Week-0.77%
Market Cap80.52B Forward P/E13.42 EPS next Y15.98 Insider Trans1.67% Shs Float374.51M Perf Month11.29%
Income-1948.30M PEG- EPS next Q3.73 Inst Own88.40% Short Float6.05% Perf Quarter-5.86%
Sales14.90B P/S5.40 EPS this Y23.00% Inst Trans-0.07% Short Ratio4.41 Perf Half Y-13.11%
Book/sh215.93 P/B0.99 EPS next Y19.42% ROA10.30% Target Price260.11 Perf Year-26.75%
Cash/sh73.00 P/C2.94 EPS next 5Y12.26% ROE18.70% 52W Range184.50 - 301.98 Perf YTD2.18%
Dividend2.80 P/FCF34.01 EPS past 5Y-50.40% ROI-1.30% 52W High-28.94% Beta1.07
Dividend %1.30% Quick Ratio3.90 Sales past 5Y33.40% Gross Margin83.30% 52W Low16.30% ATR5.06
Employees31200 Current Ratio4.00 Sales Q/Q4.40% Oper. Margin-9.80% RSI (14)59.65 Volatility2.20% 2.35%
OptionableYes Debt/Eq0.39 EPS Q/Q52.20% Profit Margin94.40% Rel Volume0.61 Prev Close216.56
ShortableYes LT Debt/Eq0.37 EarningsFeb 08 BMO Payout0.00% Avg Volume5.13M Price214.58
Recom2.00 SMA202.53% SMA506.91% SMA200-5.25% Volume3,137,152 Change-0.91%
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-07-16Downgrade Susquehanna Positive → Neutral
Jan-19-17 09:35AM  Bull-Bear Battle Coming to a Head for Allergan at Investopedia
09:30AM  Should Value Investors Choose Allergan (AGN)?
09:04AM  Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
08:07AM  Allergan says the FDA has approved its cream for facial redness at MarketWatch
07:59AM  Allergan Announces FDA Approval Of RHOFADE (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults PR Newswire
Jan-18-17 04:27PM  Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids at The Wall Street Journal
04:22PM  Allergan's Uterine Fibroids Candidate Positive in Phase III
07:25AM  Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions
12:30AM  PRESS DIGEST- Wall Street Journal - Jan 18 Reuters
Jan-17-17 05:49PM  [$$] Allergan Admits to Disclosure Violations During Valeant Bid at The Wall Street Journal
10:33AM  AGN Falls Despite Positive Trial Results at Investopedia
02:01AM  Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids PR Newswire
Jan-16-17 01:00AM  Allergan, Schlumberger, IBM: Doug Kass' Views
Jan-14-17 05:59AM  Jobless Claims and Trimming GLD: Best of Kass
Jan-12-17 02:45PM  Pharma company executives debate drug pricing increases
02:00PM  Lawsuit accuses Shire of monopolizing market for ADHD drug at bizjournals.com
08:00AM  Allergan to Report Fourth Quarter and Full Year 2016 Earnings and Host Conference Call and Webcast PR Newswire
Jan-11-17 07:01PM  Cramer: Trump Doesn't Seem to Care About the Trump Rally
04:16PM  Correction: Drug Prices-Johnson & Johnson story
02:22PM  Mylan CEO Heather Bresch says keeping drug price hikes below 10% isnt the answer at MarketWatch
01:26PM  Trump's Comments Are Big Pharma's Nightmare at Forbes
12:31PM  Stocks Recover But Pharma Still Down After Trump's Threats at Forbes
12:26PM  Trump's Comments Are Big Pharma's Nightmare
08:36AM  Allergan Shifts Strategy to Focus on Growth at TheStreet
Jan-10-17 08:01PM  Allergan Hints It Is Ready to Make a Splash for More Near-term Growth
04:51PM  Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation
04:06PM  5 Manufacturing Stocks With 25% Upside Potential
12:59PM  Todd Hagopian's Top Biotech Takeover Targets For 2017 at Forbes
12:45PM  Allergan CEO: Seeing constructive movement by entire indu...
09:09AM  Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes at Motley Fool
Jan-09-17 03:47PM  AGN Makes Two Small Deals at Investopedia
03:05PM  Allergan wants to buy a Cambridge biotech founded by ex-Genzyme CEO at bizjournals.com
11:21AM  Teva Pharmaceutical Industries Ltd -- Moody's: Operating Headwinds Weigh On Teva's 2017 Deleveraging Plans -- A Credit Negative at Moody's
11:13AM  [video]Allergan Continues Down 'Stepping Stone' Path With Two Deals
08:30AM  Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds PR Newswire
08:00AM  Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs PR Newswire
08:00AM  Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs GlobeNewswire
07:39AM  Teva Falls on Disappointing 2017 Sales & Earnings Guidance
01:00AM  Allergan, Google, Oaktree Capital: Doug Kass' Views
Jan-07-17 03:03PM  These 9 Allergan Drugs May Now Cost as Much as 9.5% More in 2017
Jan-06-17 09:00PM  Craft a Strategy From Retail's Wreckage: Best of Kass
08:09PM  Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)
04:22PM  ALLERGAN PLC Files SEC form 8-K, Change in Directors or Principal Officers
03:26PM  Teva Pharmaceutical: What the Heck Does 'Focused on Execution' Mean Anyway? at Barrons.com
01:26PM  Allergan CEO on the Hot Seat: Here's What He Had to Say at Motley Fool
07:24AM  Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 View
Jan-05-17 04:01PM  Allergan Pops On 2017 Guidance; Can It Survive Alzheimer's Rivalries?
03:38PM  Allergan: No More "Aspirational" Financial Guidance at Barrons.com
12:52PM  Cooperman's best ideas: 14 stock picks
11:19AM  Allergan Is Playing Its Cards Close To The Vest at Investopedia
10:07AM  Saunders Paints Realistic Outlook for Allergan in 2017
08:57AM  Allergan issues 2017 guidance, expects double-digit EPS growth at MarketWatch
08:29AM  How Trump-related uncertainty is bringing out the health-care stock bears at MarketWatch
08:16AM  Allergan (AGN) Liletta sNDA Accepted for Review in the U.S.
07:52AM  Allergan expects mid-single digit 2017 revenue growth
07:30AM  Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook PR Newswire
06:45AM  What Pharma and Healthcare Investors Should Watch For at JPM Next Week
Jan-04-17 11:14AM  Allergan Plc (AGN) Explodes After FDA Approval Of Natrelle Inspira at Insider Monkey
08:33AM  Allergan Natrelle Inspira Breast Implants Approved in the U.S.
07:35AM  FDA Accepts For Filing Supplemental New Drug Application (sNDA) For LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg PR Newswire
Jan-03-17 07:20PM  Abraham, Fruchter & Twersky, LLP Files Securities Class Action Lawsuit Against Allergan PLC (NYSE: AGN) Marketwired
04:15PM  Allergan to Present at 35th Annual J.P. Morgan Healthcare Conference PR Newswire
02:42PM  New year, new drug prices
12:32PM  Allergan Drug Price Hikes Are in Effect, Though Increases Are Modest at TheStreet
11:01AM  Allergan Continues 2017 Where It Left Off In 2016 at Investopedia
10:31AM  EQUITY UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan PLC - AGN PR Newswire
09:48AM  Allergan took its pricing pledge last fall about as literally as it gets at MarketWatch
07:35AM  Allergan Announces FDA Approval of NATRELLE INSPIRA® SoftTouch Breast Implants PR Newswire
Jan-02-17 10:25AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses In Excess of $100,000 of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017 Accesswire
01:00AM  Starbucks, Allergan, Amazon: Doug Kass' Views
Dec-30-16 01:15PM  Apollo Endosurgery Shares Up 20% After Going Public With Reverse Merger
11:15AM  3 Sleeper Biotechs That Could Bounce Back Strong in 2017
10:30AM  GPM Reminds Investors of the January 3 Deadline in the Class Action Lawsuit Against Allergan PLC Business Wire
08:58AM  Apple and Microsoft: Moving Opposite on Share Buybacks?
08:00AM  Brent Saunders's New Model Will Be Tested in 2017 at Bloomberg
07:35AM  Analyzing Mercks General Medicine and Womens Health Segment
Dec-29-16 04:19PM  Bulls Are Pushing Allergan Shares Higher at Investopedia
10:10AM  DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) & Lead Plaintiff Deadline: January 3, 2017 GlobeNewswire
07:00AM  Healthcare: What Does a Trump Administration Mean for Healthcare Stocks? at Morningstar
Dec-28-16 03:42PM  January 3 Deadline Alert: Law Offices of Howard G. Smith Reminds Allergan PLC Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Business Wire
03:05PM  DEADLINE ALERT: Brower Piven Reminds Investors Of The January 3, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Allergan plc To Contact The Firm - AGN GlobeNewswire
09:06AM  VRXs Gastrointestinal Segment Saw Robust Revenue Growth in 2016
06:52AM  Biotech plays for the new year
Dec-27-16 02:13PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Allergan plc To Contact The Firm Before Lead Plaintiff Deadline Accesswire
11:53AM  Shares of Allergan Showing Positive Momentum at Investopedia
11:00AM  Biotech Poised for Rebound
10:02AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017 Accesswire
Dec-26-16 09:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline AGN GlobeNewswire
Dec-25-16 10:05PM  Asian stocks lower in light trading after Christmas
Dec-23-16 07:01PM  Cramer: Count Your Blessings, It's OK to Like Stocks Again
04:48PM  ALLERGAN ALERT: Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action Filed by Firm - AGN GlobeNewswire
04:37PM  US stocks inch higher in slow pre-holiday trading
04:04PM  Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse
02:52PM  Allergan Is Gaining Traction -- Plus Jim Cramer's Take
09:30AM  The Zacks Analyst Blog Highlights: FedEx, Verizon, Morgan Stanley, Caterpillar and Allergan
08:35AM  Ironwood, Allergan Report Positive Linzess IBS-C Study Data
05:48AM  Pharma Stock Roundup: J&J Back in Talks with Actelion, Teva Settles Corruption Probe
Dec-22-16 03:00PM  Allergan plc Board of Directors Issues Statement on Company's Social Contract with Patients PR Newswire
01:33PM  Top Research Reports for FedEx, Verizon & Morgan Stanley
11:20AM  Cambridge's Ironwood reports positive data on constipation drug at bizjournals.com
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
ADBE Adobe Systems Incorporated daily Stock Chart
ADBE [NASD]
Adobe Systems Incorporated
IndexS&P 500 P/E55.93 EPS (ttm)1.96 Insider Own0.38% Shs Outstand497.50M Perf Week0.73%
Market Cap54.62B Forward P/E22.91 EPS next Y4.79 Insider Trans-9.09% Shs Float494.69M Perf Month6.03%
Income991.90M PEG1.79 EPS next Q0.87 Inst Own87.80% Short Float0.88% Perf Quarter1.26%
Sales5.55B P/S9.84 EPS this Y135.20% Inst Trans0.03% Short Ratio1.69 Perf Half Y11.58%
Book/sh14.60 P/B7.52 EPS next Y25.54% ROA8.20% Target Price122.76 Perf Year24.85%
Cash/sh8.94 P/C12.28 EPS next 5Y31.21% ROE13.90% 52W Range71.27 - 111.09 Perf YTD6.64%
Dividend- P/FCF31.41 EPS past 5Y-3.40% ROI7.40% 52W High-1.17% Beta1.05
Dividend %- Quick Ratio2.20 Sales past 5Y4.80% Gross Margin85.50% 52W Low54.05% ATR1.67
Employees13893 Current Ratio2.20 Sales Q/Q20.20% Oper. Margin23.60% RSI (14)65.22 Volatility1.31% 1.40%
OptionableYes Debt/Eq0.00 EPS Q/Q55.90% Profit Margin17.90% Rel Volume1.20 Prev Close108.79
ShortableYes LT Debt/Eq0.26 EarningsDec 15 AMC Payout0.00% Avg Volume2.57M Price109.79
Recom2.00 SMA203.42% SMA504.46% SMA2008.54% Volume3,090,488 Change0.92%
Jan-12-17Downgrade Pivotal Research Group Buy → Hold $136 → $104
Jan-11-17Initiated Wells Fargo Market Perform
Jan-05-17Initiated BMO Capital Markets Outperform $125
Nov-03-16Reiterated Wunderlich Hold $99 → $115
Sep-21-16Reiterated RBC Capital Mkts Outperform $115 → $116
Sep-21-16Reiterated Pivotal Research Group Buy $124 → $125
Jul-26-16Initiated Piper Jaffray Overweight $125
Jun-22-16Reiterated UBS Buy $114 → $122
Jun-22-16Reiterated Rosenblatt Buy $112 → $120
Apr-21-16Resumed Credit Suisse Neutral $85 → $105
Apr-12-16Reiterated FBR Capital Mkt Perform $100 → $115
Apr-04-16Reiterated Dougherty & Company Buy $116 → $122
Mar-31-16Initiated Canaccord Genuity Buy $110
Mar-18-16Reiterated Wunderlich Hold $94 → $99
Mar-18-16Reiterated UBS Buy $105 → $114
Mar-18-16Reiterated RBC Capital Mkts Outperform $101 → $104
Mar-18-16Reiterated Dougherty & Company Buy $114 → $116
Jan-14-16Initiated Dougherty & Company Buy $114
Dec-14-15Reiterated Argus Buy $95 → $110
Dec-11-15Reiterated Wunderlich Hold $90 → $94
Jan-19-17 05:38PM  The US says Oracle is encouraging Indians to hire others Indiansand its killing diversity
05:35PM  Why Salesforce Has to Be Ambitious in Revenue Growth at Market Realist
04:42PM  Starbucks latest to expand parental leave benefits AP
02:44PM  APG Sells Adobe Systems Shares in 3Q16 (ADBE) at Investopedia
Jan-18-17 03:45PM  Adobe's Board OKs $2.5 Billion Share Buyback at Investopedia
10:10AM  Stock Market News for January 18, 2017
08:45AM  Adobe Gets Authorization to Repurchase Shares Worth $2.5B
08:28AM  Early movers: GS, TGT, UAL, CSX, NFLX, ADBE & more at CNBC
04:16AM  The CEO of ad tech firm TubeMogul explains why he sold his company to Adobe for $540 million and what happens now Business Insider
Jan-17-17 04:34PM  Pivotal Verifies Hold Rating for Adobe (ADBE) at Investopedia
04:19PM  ADOBE SYSTEMS INC Files SEC form 8-K, Other Events
04:19PM  Adobe System's board OKs $2.5B share buyback program at MarketWatch
04:05PM  Adobe Announces Program to Repurchase $2.5 Billion of Stock by End of FY2019 Business Wire
10:40AM  10 Biggest Cloud Computing Companies in the World at Insider Monkey
08:55AM  3 Top SaaS Companies to Buy Today at Motley Fool
08:52AM  Microsoft Acquires Maluuba, Expands in IoT and AI Markets
08:16AM  Can Adobe Lead in Digital Asset Management? (ADBE) at Investopedia
Jan-14-17 12:01AM  [$$] Credit Suisse Likes Expedia's Mash-Up of Brands at Barrons.com
Jan-13-17 12:56PM  Adobe Demos Voice-Controlled Photo Editing at Forbes
09:44AM  The Cure for the Annual Performance Review Is More Reviews
09:44AM  Performance Reviews Are Making Us Cry. We Might Not Like the Cure at Bloomberg
08:19AM  Why Splunk's Lower Guidance Should Make Investors Nervous at TheStreet
Jan-12-17 03:24PM  8 Stocks Jim Cramer Likes if the U.S. Economy Rebounds
02:50PM  Adobe Tries for Voice-Controlled Virtual Assistant at Investopedia
01:16PM  Morgan Stanley Adds Adobe Shares (MS, ADBE) at Investopedia
08:41AM  Adobe Systems downgraded by Pivotal Research Group
08:26AM  Zacks Upgrades Rating of Adobe Shares (ADBE) at Investopedia
Jan-11-17 02:45PM  Former Macy's Executive Rodriguez: Here's How To Regain Comp Store Sales
10:10AM  Stock Market News for January 11, 2017
09:56AM  Performance Review Peril: Adobe Study Shows Office Workers Waste Time and Tears Business Wire
07:58AM  Adobe Raises Revenue Guidance After TubeMogul Acquisition
Jan-10-17 04:10PM  How Will Adobe Systems Perform in 1QFY17? (ADBE) at Investopedia
02:33PM  Adobe Systems VP Sells 1,348 Shares (ADBE) at Investopedia
10:19AM  [$$] Adobe Co-Founder Sells $5 Million in Stock at Barrons.com
07:51AM  Buy Adobe Now -- Plus Jim Cramer's Take at TheStreet
Jan-09-17 04:40PM  Vetr Upgrades Adobe Shares to Buy (ADBE) at Investopedia
01:02PM  ShearLink Lowers Stake in Adobe Shares (ADBE) at Investopedia
12:49PM  Adobe Shares Rise 10.4 Percent in 2016 (ADBE) at Investopedia
11:23AM  Limited Stores Closes All 250 Stores as Another Retail Bankruptcy Looms
Jan-07-17 05:28PM  Why Adobe Systems Stock Rose 10.4% in 2016 at Motley Fool
10:10AM  Gigantic Tech and Financial Trades Dominate New Year Insider Selling: Google, Adobe Systems, Charles Schwab, Ingersoll-Rand and More
Jan-06-17 05:40PM  Adobe Should Shop for a Digital Commerce Platform: BMO Capital
03:10PM  Here are the 7 jobs that pay $100K or more on Glassdoor's 'Best Places to Work' list at bizjournals.com
11:09AM  Adobe Co-Chairman Sells 48,100 Shares (ADBE) at Investopedia
08:15AM  Adobe Systems, Inc. breached its 50 day moving average in a Bullish Manner : ADBE-US : January 6, 2017
Jan-05-17 04:43PM  Adobe Initiated At Buy; Palo Alto Networks, Fortinet At Neutral
04:14PM  Amazon Wins Christmas, And Its 50-Day, As Macy's, Malls Mauled
03:57PM  [$$] Cloud Stocks Ready to Bolt Upwards in 2017 at Barrons.com
01:00PM  Adobe to Host Conference Call to Discuss TubeMogul Acquisition Business Wire
12:41PM  BMO Gives Adobe Shares an Outperform Grade (ADBE) at Investopedia
11:43AM  Looking To Invest In The Cloud? 7 Stocks To Own In 2017
Jan-04-17 07:01PM  Cramer: Skies Brightening for Cloud Group at TheStreet
12:16PM  Why Salesforce Investors Shouldn't Worry About Firm's Lack of Big M&A Deals at TheStreet
Jan-03-17 12:20PM  ETFs with exposure to Adobe Systems, Inc. : January 3, 2017
Dec-30-16 04:00PM  Adobe Systems CEO Touts 'Textbook Transition' To Cloud
Dec-29-16 08:34AM  How AdMarketing Cloud Can Impact Adobe's Stock Price at Forbes
05:57AM  5 Blue-Chip Breakout Trades to Ring in the New Year
Dec-27-16 09:30AM  The Zacks Analyst Blog Highlights: IBM, BP, Disney, Adobe and Cisco
Dec-23-16 12:25PM  ETFs with exposure to Adobe Systems, Inc. : December 23, 2016
11:22AM  Stock Research Reports for IBM, BP & Disney
09:26AM  Shoppers on last-minute shopping surge
Dec-22-16 08:53AM  Adobe Systems, Inc. :ADBE-US: Earnings Analysis: Q4, 2016 By the Numbers : December 22, 2016
08:27AM  Adobe Systems, Inc. :ADBE-US: Earnings Analysis: 2016 By the Numbers : December 22, 2016
08:15AM  Post Earnings Coverage as Adobe Reported Record Quarterly Revenue, Net Income, Cash Flow, and Deferred Revenue Accesswire
07:35AM  What Are Analysts Recommendations for Adobe Stock? at Market Realist
Dec-21-16 11:17AM  Glassdoor Chief Economist On The Gender Wage Gap: Data Is Key To Understanding The Problem
10:36AM  How Does Adobe Measure Up in the Application Software Space? at Market Realist
09:06AM  Adobes Financial Performance in Fiscal 4Q16 at Market Realist
08:20AM  RBC Has 5 Top Large Cap Software Picks for 2017 at 24/7 Wall St.
07:36AM  Adobes Increased Initiatives to Strengthen Its Marketing Cloud at Market Realist
Dec-20-16 04:00PM  Red Hat Earnings On Tap, Public Cloud Traction Key
10:37AM  How Digital Marketing Contributed to Adobes Fiscal 4Q16 Results at Market Realist
09:18AM  Adobe Closes TubeMogul Buyout to Boost Digital Marketing
09:08AM  How Digital Media Contributed to Adobes Fiscal 4Q16 Results
07:38AM  Adobes Fiscal 4Q16 Results Beat Analysts Estimates Again at Market Realist
Dec-19-16 10:46PM  Asian stocks mixed as attacks in Germany, Turkey hike risks AP
04:05PM  Adobe Completes Acquisition of TubeMogul Business Wire
04:04PM  SaaS Stocks To Lead In Software Revenue Growth, Says RBC Capital
Dec-17-16 09:00AM  Jim Cramer's Top Takeaways: Micron Technology, Advanced Micro Devices, GTT Communications
Dec-16-16 11:06PM  [$$] Adobes Big Cloud to Fill at The Wall Street Journal
07:30PM  Week in Review: Dow Scores Sixth Week of Gains After Fed Hikes Rates at TheStreet
07:01PM  Cramer: The Bulls Needed This Breather
04:47PM  Jabil Circuit, Chipotle rise; Adobe, Oracle fall
04:38PM  Adobe Systems Sees Clear Skies Ahead For Cloud Businesses
04:23PM  Dow Backs Away From 20,000; Oil Rises, Alexion Gets A Big Bounce
04:06PM  Stocks End Unsettled Quadruple Witching Session With Slight Losses
03:08PM  Stocks Mixed; Dow 20,000 Still Elusive; Apple Climbs Near Breakout
02:21PM  Dow on Track for Sixth Straight Week of Gains Even as Markets Fall
01:13PM  [$$] Regulators step in to Yahoo's vast data breach at Financial Times
12:35PM  Oracle, Adobe React; Honeywell Hurts; Two Dividend Stocks To Consider
12:35PM  Oracle, Adobe React To Earnings; Two Dividend Stocks To Consider
12:09PM  Stocks Mixed, Mostly Unchanged; Apple Unfazed By Piper Jaffray Note
12:03PM  [$$] Adobe's Big Cloud to Fill at The Wall Street Journal
11:52AM  Disney's 'Rogue One' hits theaters; Adobe earnings top estimates; Mylan launches generic EpiPen
11:42AM  Adobe CEO: Mobile is a large opportunity for us
11:02AM  Dow Eyes 20,000 as Stocks Drift Higher
10:35AM  Adobe Guidance Disappointing, but Fourth Quarter Still Strong: What Wall Street's Saying at TheStreet
10:10AM  Stock Market News for December 16, 2016
09:55AM  Stocks to Watch: Oracle, Honeywell and DryShips at The Wall Street Journal
09:39AM  Stocks Open Higher; Upgrade Lifts GE Shares
Adobe Systems Incorporated operates as a diversified software company worldwide. Its Digital Media segment provides tools and solutions that enable individuals, small and medium businesses, and enterprises to create, publish, promote, and monetize their digital content. This segment's flagship product is Creative Cloud, a subscription service that allows customers to download and install the latest versions of its creative products. This segment serves traditional content creators, Web application developers, and digital media professionals, as well as their management in marketing departments and agencies, companies, and publishers. The company's Digital Marketing segment offers solutions for how digital advertising and marketing are created, managed, executed, measured, and optimized. This segment provides analytics, social marketing, targeting, media optimization, digital experience management, cross-channel campaign management, and audience management solutions, as well as video delivery and monetization to digital marketers, advertisers, publishers, merchandisers, Web analysts, chief marketing officers, chief information officers, and chief revenue officers. Its Print and Publishing segment offers products and services, such as eLearning solutions, technical document publishing, Web application development, and high-end printing, as well as publishing needs of technical and business, and original equipment manufacturers (OEMs) printing businesses. The company markets and licenses its products and services directly to enterprise customers through its sales force, as well as to end-users through app stores and through its Website at adobe.com. It also distributes products and services through a network of distributors, value-added resellers, systems integrators, independent software vendors, retailers, and OEMs. Adobe Systems Incorporated has a strategic partnership with comScore, Inc. The company was founded in 1982 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WARNOCK JOHN ECo-Chairman of the BoardJan 17Sale107.285,000536,405559,600Jan 17 04:14 PM
GESCHKE CHARLES MCo-Chairman of the BoardJan 09Sale108.5223,1002,506,775228,773Jan 09 06:24 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 06Sale108.131,348145,7600Jan 06 06:54 PM
GESCHKE CHARLES MCo-Chairman of the BoardJan 04Sale104.0348,1005,003,800251,873Jan 05 04:20 PM
WARNOCK JOHN ECo-Chairman of the BoardDec 19Sale105.416,000632,472565,600Dec 21 04:43 PM
Morris DonnaEVP, Cust. & Emp. ExperienceOct 10Sale110.0010,0001,100,00054,279Oct 11 04:43 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryOct 10Sale109.6413,3311,461,57930,993Oct 11 04:41 PM
WARNOCK JOHN ECo-Chairman of the BoardSep 27Sale106.995,000534,950571,600Sep 27 04:49 PM
ROSENSWEIG DANIELDirectorSep 26Sale107.4213,0001,396,4266,268Sep 27 04:47 PM
DALEY JAMES EDirectorSep 22Option Exercise33.236,276208,55134,362Sep 23 05:00 PM
DALEY JAMES EDirectorSep 22Sale108.006,276677,80828,086Sep 23 05:00 PM
GARRETT MARKEVP, CFO & Asst. SecretarySep 06Sale103.4726,8992,783,3120Sep 06 07:01 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 29Sale101.855,450555,08344,324Aug 29 06:11 PM
Lewnes AnnEVP, Chief Marketing OfficerAug 26Sale101.6813113,32042,968Aug 29 04:29 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 23Option Exercise0.0027,500064,123Aug 24 04:08 PM
GARRETT MARKEVP, CFO & Asst. SecretaryAug 16Option Exercise0.0056,250056,250Aug 17 04:31 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Option Exercise34.032,33579,46076,614Aug 11 04:05 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.0010,0001,000,00064,279Aug 11 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.002,335233,50074,279Aug 11 04:05 PM
Lewnes AnnEVP, Chief Marketing OfficerJul 29Sale98.404,000393,60043,099Aug 01 04:09 PM
DALEY JAMES EDirectorJul 20Option Exercise33.235,000166,15033,086Jul 21 04:08 PM
WARNOCK JOHN ECo-Chairman of the BoardJul 20Sale98.512,000197,024579,115Jul 21 04:10 PM
DALEY JAMES EDirectorJul 20Sale98.505,000492,50028,086Jul 21 04:08 PM
BARNHOLT EDWARD WDirectorJul 11Option Exercise37.0925,000927,25058,124Jul 11 05:56 PM
BARNHOLT EDWARD WDirectorJul 11Sale97.2525,0002,431,13333,124Jul 11 05:56 PM
Rencher BradleyEVP & GM, Digital MarketingJul 01Sale95.4637,5623,585,62747,269Jul 01 05:38 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJul 01Sale95.6827125,9291,348Jul 01 04:13 PM
LAMKIN BRYANEVP & GM, Digital MediaJul 01Sale95.049,616913,90523,665Jul 01 04:10 PM
WARNOCK JOHN ECo-Chairman of the BoardJun 30Sale95.154,000380,605581,115Jul 01 04:09 PM
ROSENSWEIG DANIELDirectorJun 29Sale92.9819,3001,794,57419,268Jul 11 04:57 PM
Lewnes AnnEVP, Chief Marketing OfficerJun 24Sale92.394,000369,56046,828Jun 24 04:32 PM
Lewnes AnnEVP, Chief Marketing OfficerMay 27Sale99.404,000397,59650,828May 31 04:09 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryMay 10Sale95.099,466900,16736,409May 11 04:17 PM
Lewnes AnnEVP, Chief Marketing OfficerApr 29Sale92.894,000371,56054,828May 02 04:29 PM
WARNOCK JOHN ECo-Chairman of the BoardApr 12Option Exercise0.003,4260581,129Apr 14 04:49 PM
CALDERONI FRANKDirectorApr 12Option Exercise0.003,426021,051Apr 14 04:47 PM
BARNHOLT EDWARD WDirectorApr 12Option Exercise0.003,426033,124Apr 14 04:45 PM
Desmond LauraDirectorApr 12Option Exercise0.003,426021,051Apr 14 04:43 PM
BURGESS ROBERT KDirectorApr 12Option Exercise0.003,426038,124Apr 14 04:42 PM
Banse AmyDirectorApr 12Option Exercise0.003,426027,791Apr 14 04:36 PM
ROSENSWEIG DANIELDirectorApr 12Option Exercise0.003,426051,568Apr 14 04:34 PM
DALEY JAMES EDirectorApr 12Option Exercise0.003,426028,086Apr 14 04:32 PM
GESCHKE CHARLES MCo-Chairman of the BoardApr 12Option Exercise0.003,4260299,973Apr 14 04:27 PM
SEDGEWICK ROBERTDirectorApr 12Option Exercise0.003,426079,347Apr 13 05:22 PM
CANNON MICHAEL RDirectorApr 12Option Exercise0.003,426033,124Apr 13 05:20 PM
Barlow Kelly JDirectorApr 12Option Exercise0.003,42603,426Apr 13 06:23 PM
WARNOCK JOHN ECo-Chairman of the BoardApr 12Sale93.295,000466,458577,703Apr 12 05:32 PM
ROWLEY RICHARDVP, Corp. Controller & CAOApr 09Option Exercise0.002,81702,817Apr 12 05:34 PM
DALEY JAMES EDirectorApr 01Option Exercise33.825,000169,10029,660Apr 01 07:35 PM
NARAYEN SHANTANUPresident and CEOApr 01Option Exercise34.0322,422763,021321,394Apr 01 07:31 PM
NARAYEN SHANTANUPresident and CEOApr 01Sale94.8522,4222,126,678298,972Apr 01 07:31 PM
ROWLEY RICHARDVP, Corp. Controller & CAOApr 01Sale95.058,780834,5500Apr 01 07:28 PM
DALEY JAMES EDirectorApr 01Sale95.005,000475,00024,660Apr 01 07:35 PM
ValueAct Holdings, L.P.DirectorMar 31Sale93.992,767,739260,127,4666,000Mar 31 05:43 PM
DALEY JAMES EDirectorMar 30Option Exercise33.822,84096,04927,500Apr 01 07:35 PM
DALEY JAMES EDirectorMar 30Sale94.002,840266,96024,660Apr 01 07:35 PM
ValueAct Holdings, L.P.DirectorMar 30Sale93.764,000,000375,040,0002,773,739Mar 31 05:43 PM
ValueAct Holdings, L.P.DirectorMar 29Sale92.971,965,580182,739,9736,773,739Mar 31 05:43 PM
ValueAct Holdings, L.P.DirectorMar 28Sale92.53100,0009,253,0008,739,319Mar 28 05:06 PM
ValueAct Holdings, L.P.DirectorMar 24Sale92.51821,80876,025,4588,839,319Mar 28 05:06 PM
ROWLEY RICHARDVP, Corp. Controller & CAOMar 24Sale92.464,146383,3498,780Mar 25 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceMar 22Sale93.0025,0002,325,00074,008Mar 23 04:38 PM
GESCHKE CHARLES MCo-Chairman of the BoardMar 21Option Exercise42.6125,0001,065,250321,547Mar 23 04:33 PM
WARNOCK JOHN ECo-Chairman of the BoardMar 21Sale92.709,000834,309587,703Mar 23 04:35 PM
GESCHKE CHARLES MCo-Chairman of the BoardMar 21Sale92.4825,0002,311,875296,547Mar 23 04:33 PM
Lewnes AnnEVP, Chief Marketing OfficerFeb 26Sale86.314,000345,23362,828Feb 29 06:02 PM
Lewnes AnnEVP, Chief Marketing OfficerFeb 03Option Exercise34.032,28077,58866,828Feb 05 04:14 PM
NARAYEN SHANTANUPresident and CEOFeb 01Option Exercise34.0322,422763,021321,394Feb 02 04:35 PM
NARAYEN SHANTANUPresident and CEOFeb 01Sale88.8022,4221,991,007298,972Feb 02 04:35 PM
ValueAct Holdings, L.P.DirectorJan 29Sale89.01185,00016,466,85011,773,739Feb 02 04:31 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 29Sale86.234,000344,90264,548Feb 01 04:37 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 29Sale86.2510,310889,28045,875Feb 01 04:31 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 26Sale86.8473,0006,338,99951,718Jan 27 04:34 PM
ValueAct Holdings, L.P.DirectorJan 25Sale89.005,000445,00011,958,739Jan 25 06:25 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 25Sale88.5253,3954,726,7490Jan 27 04:43 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 24Option Exercise0.0061,567074,673Jan 27 04:45 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 24Option Exercise0.00108,359078,348Jan 27 04:43 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJan 24Option Exercise0.0076,4750121,109Jan 27 04:41 PM
LAMKIN BRYANEVP & GM, Digital MediaJan 24Option Exercise0.0017,184027,464Jan 27 04:39 PM
Rencher BradleyEVP & GM, Digital MarketingJan 24Option Exercise0.00108,2000112,252Jan 27 04:36 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 24Option Exercise0.00149,3590169,665Jan 27 04:34 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 24Option Exercise0.0020,930017,893Jan 27 04:32 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 24Option Exercise0.0076,475090,649Jan 27 04:28 PM
ValueAct Holdings, L.P.DirectorJan 22Sale89.271,612,000143,903,24011,963,739Jan 25 06:25 PM
ValueAct Holdings, L.P.DirectorJan 21Sale89.56435,00038,958,60013,575,739Jan 25 06:25 PM
SHPG Shire plc daily Stock Chart
SHPG [NASD]
Shire plc
Index- P/E61.77 EPS (ttm)2.66 Insider Own0.10% Shs Outstand295.46M Perf Week-3.22%
Market Cap48.49B Forward P/E10.76 EPS next Y15.25 Insider Trans0.00% Shs Float181.49M Perf Month-4.63%
Income411.00M PEG4.31 EPS next Q3.24 Inst Own23.30% Short Float0.45% Perf Quarter-13.94%
Sales9.31B P/S5.21 EPS this Y-59.40% Inst Trans0.61% Short Ratio0.62 Perf Half Y-15.97%
Book/sh99.26 P/B1.65 EPS next Y17.79% ROA0.30% Target Price241.15 Perf Year-6.89%
Cash/sh2.47 P/C66.55 EPS next 5Y14.33% ROE0.80% 52W Range146.88 - 209.22 Perf YTD-3.68%
Dividend0.80 P/FCF- EPS past 5Y16.50% ROI12.00% 52W High-21.56% Beta1.53
Dividend %0.49% Quick Ratio0.60 Sales past 5Y13.10% Gross Margin67.60% 52W Low11.73% ATR3.55
Employees5548 Current Ratio1.30 Sales Q/Q108.60% Oper. Margin6.30% RSI (14)37.00 Volatility1.53% 1.74%
OptionableYes Debt/Eq0.80 EPS Q/Q-150.90% Profit Margin1.60% Rel Volume0.89 Prev Close166.41
ShortableYes LT Debt/Eq0.70 EarningsJan 31 BMO Payout42.60% Avg Volume1.31M Price164.11
Recom1.70 SMA20-4.44% SMA50-5.23% SMA200-10.70% Volume1,162,915 Change-1.38%
Dec-02-16Initiated Societe Generale Buy
Sep-26-16Downgrade HSBC Securities Buy → Hold
Jun-03-16Reiterated Jefferies Buy $223 → $262
May-26-16Initiated Stifel Buy $230
May-06-16Initiated Liberum Buy
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-10-16Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $240
Feb-10-16Initiated Guggenheim Neutral
Jan-15-16Upgrade BofA/Merrill Neutral → Buy
Jan-12-16Upgrade Credit Suisse Neutral → Outperform
Jan-12-16Reiterated RBC Capital Mkts Sector Perform $248 → $240
Nov-17-15Upgrade Leerink Partners Mkt Perform → Outperform $239
Nov-03-15Upgrade HSBC Securities Hold → Buy
Oct-26-15Reiterated RBC Capital Mkts Sector Perform $263 → $248
Oct-14-15Initiated Northland Capital Outperform $288
Sep-30-15Upgrade HSBC Securities Reduce → Hold
Aug-06-15Downgrade Exane BNP Paribas Outperform → Neutral
Jul-16-15Resumed Berenberg Buy
Apr-29-15Initiated Exane BNP Paribas Outperform
Jan-26-15Reiterated RBC Capital Mkts Sector Perform $238 → $248
Jan-19-17 10:00AM  Is Shire plc a Great Stock for Value Investors?
07:00AM  U.S. FDA Acknowledges Receipt of Shire's New Drug Application for SHP465 for ADHD PR Newswire
Jan-18-17 12:37PM  Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug
Jan-17-17 12:24PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Jan-13-17 11:56AM  FTSE 100 continues record run, rising for 14th day in a row at MarketWatch
Jan-12-17 02:34PM  KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market Opportunity'
02:00PM  Lawsuit accuses Shire of monopolizing market for ADHD drug at bizjournals.com
12:20PM  Drug makers, auto stocks yank European stocks lower for first time in 3 days at MarketWatch
Jan-11-17 08:23PM  PRESS DIGEST- Financial Times - Jan 12 Reuters
04:32PM  [$$] Shire to Pay $350 Million to Settle Dermagraft Kickback Allegations at The Wall Street Journal
02:45PM  Pharmaceutical company agrees to landmark settlement in Tampa federal court at bizjournals.com
01:40PM  Trump slams drug industry at press conference, sending biotech stocks tumbling at bizjournals.com
12:21PM  FTSE 100 logs 10th day of all-time highs at MarketWatch
Jan-10-17 01:17PM  Shire CEO: Our innovation score is very high
Jan-09-17 05:35PM  Martin Whitman Invests in Homebuilder in 4th Quarter
01:55PM  Merrimack Pharma to Sell Cancer Drugs for $1B at Investopedia
Jan-06-17 04:22PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
10:46AM  For Shire PLC (ADR) (SHPG) Securing Hemophilia Market With Long Acting Version Is Crucial at Insider Monkey
Jan-05-17 02:40PM  Here's what to expect from Mass. biotechs at this weekend's J.P. Morgan conference at bizjournals.com
12:52PM  Cooperman's best ideas: 14 stock picks
12:03PM  Billionaire James Dinan Betting On These Stocks To Recover Losses at Insider Monkey
Jan-04-17 05:14PM  SHIRE PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
09:30AM  Shire to Present at the 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-03-17 05:31PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Dec-30-16 06:17AM  Pharma Stock Roundup: Cempra Plunges to 52-Week Low, Shire Drug Label Expanded
Dec-28-16 10:18AM  Shire Gets FDA Approval for Label Expansion of Adynovate
08:15AM  Blog Coverage Shire Receives FDA Approval for ADYNOVATE for Use in Children Under 12 Years Accesswire
Dec-27-16 07:00AM  Shire Announces FDA Approval of Adynovate® for use in Children and Surgical Settings PR Newswire
06:00AM  Most Important Mergers and Acquisitions of 2016 at Investopedia
Dec-23-16 05:12PM  Third Avenue Value Fund Buys 2 Stocks and Adds to 2 Positions in Q4
Dec-22-16 11:20AM  Shire Could Have A Game Changer In The Making
11:10AM  AmerisourceBergen urges stockholders to reject unsolicited 'mini-tender' offer at bizjournals.com
Dec-19-16 03:59PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
07:35AM  The Most Expensive Drugs of 2016 at Motley Fool
Dec-16-16 01:04PM  5 Biggest Acquisitions of 2016 at Motley Fool
Dec-15-16 01:00PM  American Blood Gives a Boost to Asias Most Valuable Drugmaker at Bloomberg
11:48AM  Shire PLC (ADR) (SHPG) Looks To Xenetic Biosciences Inc (XBIO) To Cement Hemophilia Market Share at Insider Monkey
09:47AM  A Primer On NASH
01:39AM  Is Shinhan Financial Group Co., Ltd. (ADR) (SHG) Going To Burn Investors? at Insider Monkey
Dec-09-16 04:12PM  Allergan Unhappy with Patent Office Decision to Allow Mylan Challenge to Restasis Patents
03:38PM  Best Midcap Stocks To Buy According To Billionaire Loeb at Insider Monkey
Dec-05-16 08:15AM  Blog Coverage Shire Announced Successful Results of its Phase III Investigational Study of VONVENDI(TM) Accesswire
Dec-04-16 06:05PM  5 Healthcare Stocks Billionaires Love The Most at Insider Monkey
Dec-02-16 05:21PM  Shire Reports on Four Decades of Real-World Safety Experience With FEIBA® PR Newswire
04:32PM  Shire Loses Ground To Allergan In Thanksgiving Week Dry-Eye Scripts
04:16PM  SHIRE PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
11:02AM  Topline Results of Phase 3 Investigational Study of VONVENDI Meets Primary Endpoint Effectively Controlling Bleeding and Blood Loss During Surgical Procedures PR Newswire
08:36AM  Coverage initiated on Shire plc by Societe Generale
Dec-01-16 04:29PM  John Paulson's Largest 3rd Quarter Trades
12:42PM  Is Smart Money Turning More Positive on Bed Bath & Beyond Inc. (BBBY)? at Insider Monkey
09:30AM  What Does Smart Money Think about Avery Dennison Corp (AVY)? at Insider Monkey
Nov-30-16 09:58AM  Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov-29-16 08:23AM  Momenta stock jumps nearly 10% on positive late-stage results for Humira biosimilar at MarketWatch
Nov-28-16 04:34PM  Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan
01:11PM  5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy at Insider Monkey
Nov-25-16 05:18AM  Actelion Soars as Johnson & Johnson 'Makes Takeover Proposal'
Nov-24-16 03:31PM  Do Hedge Funds Love PulteGroup, Inc. (PHM)? at Insider Monkey
Nov-23-16 04:00PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
01:42PM  Top Investors Are Abandoning Shire PLC (SHPG) in Droves at Insider Monkey
Nov-22-16 10:29AM  Shire to lease Genzyme headquarters, plans to hire another 400 at bizjournals.com
07:00AM  Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass. PR Newswire
Nov-21-16 02:20PM  Hayman Capital Closes Huge McDonalds (MCD) Put Position, Turns Its Bearish Gaze on This Health Stock at Insider Monkey
Nov-17-16 11:10PM  Shire Launches Cuvitru in U.S. for Primary Immunodeficiency
Nov-16-16 07:00AM  Shire Launches CUVITRU in the U.S. for Primary Immunodeficiency PR Newswire
Nov-14-16 09:57AM  Trump Supporters Icahn, Paulson Score Huge Returns After Election Win at Insider Monkey
Nov-12-16 07:00AM  Tolerability Data for Shire's CUVITRU Accepted for Oral Presentation at the American College Of Allergy, Asthma & Immunology Annual Meeting PR Newswire
Nov-10-16 05:29PM  5 Stocks to Watch on Icahn & Paulson's Gain from Trump Win
01:04PM  SHIRE PLC Financials
07:00AM  Shire's Investor Day Showcases Strength of Rare Disease Pipeline and Commercial Portfolio PR Newswire
02:37AM  Pharma stocks propel European stocks higher after Trump win shakes markets at MarketWatch
Nov-09-16 12:24PM  FTSE 100 ends roller-coaster day higher as Trump win boosts pharma, gold shares at MarketWatch +11.50%
09:52AM  Why Merrimack Pharmaceuticals, Inc. Shares Sank 18% Lower in October at Motley Fool
Nov-07-16 12:59PM  ETFs with exposure to Shire Plc : November 7, 2016
Nov-05-16 12:12AM  [$$] Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson at The Wall Street Journal
Nov-04-16 07:21PM  Samuel Isaly Makes 9 New Buys in 3rd Quarter
11:00AM  Broad Range of Research to be Presented at ASH 2016 Demonstrates Shire's Commitment to Addressing Unmet Needs for Patients with Rare Hematologic and Specialty Conditions PR Newswire
10:04AM  Shire Plc :SHPG-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016
07:00AM  Shire to Highlight Focus on Rare Disease Innovation at Investor Day PR Newswire
Nov-02-16 04:54PM  SHIRE PLC Files SEC form 10-Q, Quarterly Report
03:32PM  [$$] Shire Hit by Fall in Sales of Hemophilia Drugs at The Wall Street Journal
10:02AM  How trader is playing upside in Shire
08:13AM  Shire (SHPG) Misses Q3 Earnings & Revenue Estimates
08:05AM  An Update on Phase 3 Studies for Soliris
08:00AM  10 Most Successful Investors in the World at Insider Monkey
Nov-01-16 02:21PM  [$$] Shire misses sales target and is hit by costs from Baxalta deal at Financial Times
01:19PM  European Stock Markets Fall As Bond Sell Off Hits Dividend Yielders Across The Board
09:16AM  FTSE 100 wobbles as Shell rises but Shire, Standard Chartered slide at MarketWatch
08:47AM  Shire reports 3Q loss
08:37AM  Shire Reports Q3 2016 Results with Record Revenues and Reiterates Full Year Non GAAP Guidance PR Newswire
08:05AM  SHIRE PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Oct-31-16 03:55PM  5 Healthcare Stocks Poised to Trump Q3 Earnings
09:48AM  Should You Buy Shire plc (SHPG) Ahead of Earnings?
08:50AM  Celldex (CLDX): Will the Stock Surprise in Q3 Earnings?
Oct-30-16 09:50AM  Week Ahead: Fed Meeting, Jobs Report Paint Clearer Picture for Rate Hike Chances
Oct-28-16 03:44PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Oct-27-16 07:00AM  Results from Shire's Phase 2 Study of Maribavir Showed Activity Against CMV Infection in Patients Undergoing Transplant PR Newswire
Oct-20-16 10:58AM  Shire Plc : SHPG-US: Dividend Analysis : September 09th, 2016 (record date) : By the numbers : October 20, 2016
Oct-19-16 04:49PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
07:55AM  Shire Cancer Drug Onivyde Receives EU Marketing Approval
Oct-18-16 11:48AM  Merrimack's Cancer Drug Wins EU Nod (MACK, SHPG) at Investopedia
Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various products for the treatment of attention deficit hyperactivity disorder (ADHD), including VYVANSE/VENVANSE, a pro-drug stimulant; ELVANSE/TYVENSE; INTUNIV, an alpha-2A receptor agonist; EQUASYM, a methylphenidate hydrochloride; and ADDERALL XR, an extended release treatment for ADHD. The company also provides PENTASA and LIALDA/MEZAVANT for ulcerative colitis treatment; and RESOLOR, a 5-HT4 receptor agonist for oral symptomatic treatment of chronic constipation in women. In addition, it offers FOSRENOL, a phosphate binder for use in end-stage renal disease receiving dialysis; and XAGRID for the reduction of elevated platelet counts in at-risk essential thrombocythemia patients, as well as for the treatment of thrombocythemia. Further, the company provides REPLAGAL for the treatment of Fabry disease; ELAPRASE for the treatment of hunter syndrome; VPRIV for the treatment of type 1 Gaucher disease; and FIRAZYR for the symptomatic treatment of acute attacks of hereditary angioedema. Additionally, it offers FOSRENOL for the treatment of hyperphosphatemia in end stage renal disease; XAGRID for the reduction of elevated platelet counts; and CINRYZE, a C1 esterase inhibitor therapy for routine prophylaxis against hereditary angioedema. The company also licenses its patented antiviral products for human immunodeficiency virus and hepatitis B virus. Shire plc markets its products directly to government hospitals, clinics, pharmacies, and other agencies; and through wholesalers and distributors. The company sells its products in North America, the United Kingdom, the Republic of Ireland, and internationally. Shire plc has research collaboration with Santaris Pharma A/S. The company was founded in 1986 and is headquartered in Dublin, Ireland.
DAL Delta Air Lines, Inc. daily Stock Chart
DAL [NYSE]
Delta Air Lines, Inc.
IndexS&P 500 P/E8.04 EPS (ttm)6.18 Insider Own0.20% Shs Outstand743.94M